Assessing the Components of the eIF3 Complex and Their Phosphorylation Status by Farley, Adam Richard
ASSESSING THE COMPONENTS OF THE eIF3 COMPLEX AND THEIR 
PHOSPHORYLATION STATUS 
By  
Adam Richard Farley  
 
Dissertation  
Submitted to the Faculty of the  
Graduate School of Vanderbilt University  
in partial fulfillment of the requirements  
for the degree of  
DOCTOR OF PHILOSOPHY  
in  
Biochemistry 
December, 2011 
Nashville, Tennessee 
 
 
Approved: 
Professor Andrew J. Link 
Professor Richard M. Caprioli 
Professor David K. Cortez 
Professor Bruce D. Carter 
Professor Katherine L. Friedman 
 
 
 ii 
ACKNOWLEDGEMENTS 
 
 I would like to think my mentor and teacher, Dr. Andrew Link, for his guidance 
and support during this dissertation work.  Dr. Link has provided valuable insight into 
the world of science and what is necessary to solve difficult problems.  The 
experience I have gained through work at the bench, producing scientific 
communications, and teaching others mass spectrometry has proven to be both 
exciting and rewarding.  I am sure my graduate experiences in Dr. Link’s laboratory 
will continue to shape my scientific future. 
 I also want to thank Dr. Elizabeth Link for her continual commitment to editing 
and reviewing publications that I was lucky enough to take part in.  The help of 
previous lab members, Dr. David Powell, Dr. Vince Gerbasi, Dr. Morgan Sammons, 
as well as Jennifer Jennings, Connie Weaver, Dexter Duncan, and Jill McAfee was 
wonderful.  I wish the best of luck and give thanks to Chris Browne and Parimal 
Samir for taking up the role of graduate student after me.  I must also show my 
appreciation to all the students of the Proteomics courses at Cold Spring Harbor 
Laboratory.  Their questions pushed me to gain a deeper understanding of the 
science that I have been involved in than I would have otherwise considered. 
 The professors whose classrooms I have been a part of while at Vanderbilt 
deserve much credit for pushing me to explore and ask hard questions about 
science.  They have truly made my graduate career in the classroom a very 
enjoyable experience.  I hope to pass on what I have learned to future generations of 
scientists.  I want to thank the biochemistry department and its faculty and staff for 
guidance and instruction during my time here. 
 iii 
 I want to issue a heart felt thank you to all my family and friends for their 
support during my graduate career.  Even though your questions about what I was 
doing or when it would be finished may have been taxing, your support was greatly 
needed and appreciated.  Finally, I would like to thank my wife, Leah, and our three 
young daughters, Gemma, Lillian, and Isabella.  I hope one day to inspire them as 
much as they have me. 
 iv 
TABLE OF CONTENTS 
 
ACKNOWLEDGEMENTS ...................................................................................... ii  
LIST OF TABLES ................................................................................................ vii 
 
LIST OF FIGURES ............................................................................................. viii  
 
ABBREVIATIONS ................................................................................................. ix 
 
 
Chapter  
 
I.   INTRODUCTION ...................................................................................... 1 
 
  Mechanisms of protein synthesis .............................................................. 3 
  Role of the eIF3 complex ........................................................................ 11 
  Proteomic analysis of protein complexes ................................................ 16 
  Proteomic analysis of posttranslational modifications ............................. 20 
  Phosphorylation ...................................................................................... 29 
  Protein and PTM quantitation ................................................................. 37 
  Summary ................................................................................................ 41 
 
II. eIF3 INTERACTS WITH FUN12 AND HCR1 IN S. CEREVISIAE ........... 43 
  
 Abstract .................................................................................................... 43 
 Introduction .............................................................................................. 44 
 Materials and methods............................................................................. 45 
  Yeast strains ................................................................................. 45 
  Purification of eIF3 components .................................................... 45 
  Mass spectrometry analysis of purified proteins ........................... 46 
  Mass spectrometry data analysis .................................................. 47 
  Identification of phosphorylated components of eIF3 .................... 48 
 Results ..................................................................................................... 49 
  In vivo interaction of eIF3 components .......................................... 49 
  Casein kinase 2 phosphorylates Nip1, Prt1, and Tif5 in vitro ........ 57  
 Discussion ............................................................................................... 61 
 
III. DETERMINING SITES OF PHOSPHORYLATION AND THEIR  
 RELEVANCE IN Eif3 ............................................................................... 65 
 
 Abstract .................................................................................................... 65 
 Introduction .............................................................................................. 66 
 Materials and Methods............................................................................. 69 
 v 
  Plasmids ....................................................................................... 69 
  Direct mapping of phosphorylated sites on eIF3 components  
  with tandem mass spectrometry.................................................... 70 
  Mapping eIF3 phosphopeptides with IMAC enrichment and  
  tandem mass spectrometry ........................................................... 70 
  Mass spectrometry data analysis .................................................. 72 
  Scansite predictions ...................................................................... 73 
  Inhibition of in vitro phosphorylation .............................................. 73 
  Polysome profile analysis .............................................................. 74 
  Halo growth assay ......................................................................... 75 
  35S-Met incorporation .................................................................... 75 
  Quantifying the doubling times of wild-type and mutant Nip1 ........ 76 
 Results ..................................................................................................... 77 
  Mass spectrometry identification of in vivo Prt1 and Tif5  
  phosphorylation sites.......................................................................77 
  Mass spectrometry identification of in vivo phosphorylation of  
  Nip1 using IMAC enrichment ........................................................ 84 
  Phosphorylation of Nip1 at specific sites by CK2 .......................... 88 
  Phosphorylation of Nip1 at additional sites ................................... 90 
  The biological significance of Nip1 phosphorylation at S98, S99,  
  and 103 ......................................................................................... 92 
 Discussion ............................................................................................. 100 
 
IV. THE UTILITY OF USING iTRAQ with PQD ........................................... 104 
 
 Abstract .................................................................................................. 104 
 Introduction ............................................................................................ 105 
 Summary ............................................................................................... 111 
 Materials and methods........................................................................... 112 
  Protein extracts ........................................................................... 112 
  iTRAQ labeling ............................................................................ 112 
  Mass spectrometry ...................................................................... 113 
  Mass spectrometry data analysis ................................................ 112 
 Results ................................................................................................... 114 
  Experiment workflow ................................................................... 114  
  PQD versus CID for peptide identification ................................... 115 
  PQD iTRAQ reporter ion detection .............................................. 118 
 Discussion ............................................................................................. 122 
 
v. SUMMARY AND CONCLUSIONS ......................................................... 125 
 
 Part 1:  The eIF3 interactome ................................................................ 126 
  Model and future directions ......................................................... 128 
 Part 2:  The phosphorylation state of eIF3 ............................................. 129 
  The biological significance of nip1S98,99,103A .......................... 132 
  Model and future directions ......................................................... 133 
 vi 
 Part 3:  Pulsed-Q dissociation and iTRAQ ............................................. 135 
 
REFERENCES ................................................................................................. 139 
 vii 
LIST OF TABLES 
 
Table                                                                                                                    Page 
 
1-1 The composition of eIF3 in various organisms ......................................... 11 
1-2 Common PTMs encountered in mass spectrometry ................................ 21 
2-1 Mass spectrometry identification of Fun12 interactions ........................... 53 
2-2 Mass spectrometry identification of Pab1 interactions ............................. 54 
2-3 Mass spectrometry identification of CK2 interactions .............................. 55 
3-1 Summary of Nip1 peptides identified by LC-MS/MS after IMAC  
 enrichment of phosphopeptides from trypsin-digested endogenous  
 eIF3  ...................................................................................................... 86 
4-1 Proteins identified for varied PQD normalized collision dissociation 
 energies ................................................................................................. 116 
4-2 Various percent collision energies in PQD and the effect this has on  
 peptide identification and reporter ion detection .................................... 119 
 viii 
LIST OF FIGURES 
 
Figure                                                                                                     Page 
 
1-1 Translation initiation in eukaryotic cells ...................................................... 5 
1-2 Phosphorylation of eIFs altering their activities .......................................... 9 
1-3 The composition of eIF3 in various organisms ......................................... 14 
1-4 The multifactor complex ........................................................................... 27 
2-1 Purification and mass spectrometry identification of eIF3 components ... 49 
2-2 In vitro kinase screen identifies CK2 as an eIF3 kinase ........................... 57 
2-3 CK2 phosphorylates Nip1 and Prt1 in vitro .............................................. 59 
3-1  MS/MS spectra from eIF3 showing in vivo phosphorylation of Prt1 
 at S61  ...................................................................................................... 79 
3-2 MS/MS spectra from eIF3 showing in vivo phosphorylation of Prt1  
 at S61  ...................................................................................................... 80 
3-3 MS/MS spectra from eIF3 showing in vivo phosphorylation of Prt1  
 at T746 ..................................................................................................... 81 
3-4 MS/MS spectra from eIF3 showing in vivo phosphorylation of Tif5 
  at T191 ..................................................................................................... 82 
3-5 Nip1 is phosphorylated at S98, S99, and S103 ....................................... 85 
3-6 Synthetic Nip1 peptide inhibits the in vitro phosphorylation of Nip1 ......... 88 
3-7 Mutation of S98, S99, and S103 in Nip1 reduces in vivo  
 phosphorylation ....................................................................................... 90 
3-8 Mutation of S98, S99 and S103 in Nip1 increases the doubling time  
 of yeast .................................................................................................... 92 
3-9  olysome profiles of wild-type and mutant strains at    C........................ 95 
3-10 35S-methionine incorporation ................................................................... 96 
3-11 Plate growth assay .................................................................................. 97 
3-12 SM growth assay ..................................................................................... 98 
4-1 CID versus PQD spectra for a Nip1 peptide .......................................... 117 
4-2 The reporter ion series for the standard peptide  
 YNGVFQECCQAEDK............................................................................ 120 
4-3 Spectra of standard mix generated using PQD at 15%(A) 
  and 20%(B) ............................................................................................ 121 
 ix 
ABBREVIATIONS 
 
(E)-3-(2,3,4,5-Tetrabromophenyl)acrylic acid (TBCA) 
3-[(2,4,6-Trimethoxyphenyl)methylidenyl]-indolin-2-one (IC261) 
5,6-Dichloro-1-b-D-ribofuranosylbenzimidazole (DRB) 
casein kinase 2 complex (CK2) 
casein kinase I inhibitor (D4476) 
casein kinase II inhibitor (DMAT) 
casein kinase II inhibitor 1 (TBB) 
collision induced dissociation (CID) 
cross correlation score (Cn) 
doubling time (tdub) 
eIF4e binding protein (4E-BP) 
electron capture dissociation (ECD) 
electron transfer dissociation (ETD) 
electrospray ionization (ESI) 
epidermal growth factor (EGF) 
eukaryotic initiation factor (eIF) 
fused silica capillary (FSC) 
high pressure liquid chromatography (HPLC) 
higher energy c-trap dissociation (HCD) 
immobilized metal affinity chromatography (IMAC) 
isotope coded protein labeling (ICPL) 
isotope tags for relative or absolute quantification (iTRAQ) 
liquid chromatography (LC) 
mass spectrometry (MS) 
matrix assisted laser desorption ionization (MALDI) 
messenger RNA (mRNA) 
molecular weight (MW) 
multidimensional peptide identification technology (MudPIT) 
multifactor complex (MFC) 
multistage activation (MSA) 
not detected (nd) 
O-linked -N-acetylglucosamine (O-GlcNAc) 
posttranslational modification (PTM) 
protein abundance factor (PAF) 
pulsed Q dissociation (PQD) 
quadrupole-TOF (Q-TOF) 
reverse phase (RP) 
ribosomal RNA (rRNA) 
RNA recognition motif (RRM) 
strong annion exchange (SAX) 
strong cation exchange (SCX) 
sulfometuron methyl (SM) 
tandem affinity purification (TAP) 
 x 
tandem mass spectrometry (MS/MS) 
tandem mass tags (TMT) 
TAP negative control (TAP-cntrl) 
thin layer chromatography (TLC) 
time of flight (TOF) 
transfer RNA (tRNA) 
two-dimensional gel electrophoresis (2D-GE) 
1 
 
CHAPTER I 
 
INTRODUCTION 
 
This dissertation investigates the identity of proteins that interact with the 
eukaryotic translation initiation factor eIF3 and the posttranslational modifications 
that regulate eIF3‟s activity or function.  Of the three process involved in 
translation, initiation of protein synthesis is the most complex and actively studied 
since research has found this process to be aberrant in human cellular 
development disorders, diseases, and cancer (Van Der Kelen et. al., 2009; 
Jackson et. al., 2010).  A key to understanding the process of translation initiation 
is comprehensive knowledge of how the proteins involved in this process interact 
with each other and protein posttranslational modifications that modulate their 
function and activity.  These key protein-protein interactions and posttranslational 
modifications can serve to dynamically regulate eukaryotic translation initiation 
and thereby control the global rate of protein synthesis within a cell.  To this end, 
the hypothesis of my thesis is that for the essential and conserved eukaryotic 
translation initiation factor eIF3, there are unexpected and unidentified eIF3 
protein-protein interactions and protein phosphorylations that regulate its function 
and activity in the process of translation initiation.  As such, I specifically targeted 
affinity-tagged components of eIF3 to identify copurifying proteins.  Novel 
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interacting partners were validated with reciprocal protein isolations and mass 
spectrometry analysis.  The acquired mass spectrometry data was used to 
identify unexpected posttranslational modifications.  The presence of a 
copurifying protein kinase with eIF3 supported my identification of novel eIF3 
phosphorylation sites. 
Phosphorylation and other posttranslational modifications are chemical 
alterations to proteins that play a dynamic role in attenuating their biological 
functions.  Elucidating the nature of phosphorylations present on components of 
eIF3 could have implications in how this complex is regulated within cells.  
Autoradiography of 32P-labeled affinity purified eIF3 reveals that components of 
the initiation complex are indeed phosphorylated in vivo.  My proteomics data 
and in vitro kinase assays support the argument that the yeast Casein Kinase 2 
complex (CK2) selectively targets eIF3.  Mass spectrometry analysis of affinity 
purified and phosphoprotein enriched eIF3 allowed me to localize specific 
phosphorylation events to specific residues on components of eIF3. I specifically 
targeted a triply phosphorylated species of Nip1, a core component of eIF3, by 
generating point mutants lacking the identified sites of phosphorylation.  Growth 
rate assays revealed that the strains harboring nip1 mutations for the identified 
phosphorylation sites exhibit a marked increase in their doubling times. 
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Mechanisms of Protein Synthesis 
 The central dogma of molecular biology holds that genes composed of 
DNA are transcribed into RNA molecules that are in turn decoded into proteins 
(Crick, 1958; Crick, 1970).  The decoding process that messenger RNA (mRNA) 
undergoes to produce polypeptides is termed translation.  The translation of 
mRNAs is an essential cellular process and the machinery driving this process is 
composed primarily of proteins, RNAs, and individual amino acids.  The 
assembled macromolecular machinery facilitating translation is the ribosome.  An 
additional subset of proteins, translation factors, serves to regulate the function of 
the ribosome in translation.  The ribosome is composed of two subunits named 
according to their sedimentation coefficients.  In eukaryotes these two subunits 
consist of the 40S and 60S complexes.  The 40S complex contains 33 individual 
proteins as well as the 18S RNA (Dinman, 2009).  The 60S subunit is comprised 
of 46 proteins with 3 separate ribosomal RNA molecules (rRNA), 5S, 5.8S and 
the 28S (Dinman, 2009).  Short RNA molecules termed aminoacyl transfer RNAs 
(tRNAs) transfer a specified amino acid to the nascent polypeptide chain during 
translation.  These tRNAs contain a three base segment known as the anticodon 
that base pairs with the corresponding three base codon on the translating 
mRNA (Jackson et. al., 2010).  Each individual tRNA uniquely attaches to one of 
the 20 amino acids.  For active translation to occur, the 40S and 60S ribosomal 
subunits join together on an mRNA molecule through the concerted effort of the 
essential translation factors to form the 80S ribosome. 
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 Protein translation can be deconstructed into three distinct phases, 
initiation, elongation, and termination.  The first step in this process, initiation, 
consists of the events leading to the formation of the 80S ribosome primed with 
methionyl tRNA base paired at the AUG start codon. The essential and highly 
conserved process of eukaryotic translation initiation is mediated by interactions 
of numerous multi-subunit eukaryotic initiation factors (eIFs) with the ribosome, 
mRNA, and tRNAs (Figure 1-1).  In the first step, a ternary complex consisting of 
eIF2 bound to GTP and Met-tRNA is recruited to the 40S ribosomal subunit to 
form the 43S pre-initiation complex (Kimball, 1999; Unbehaun et. al., 2004).  In 
vitro experiments suggest that this interaction is promoted by the initiation factors 
eIF1, eIF1A, and eIF3 (Asano et. al., 2000; Asano et. al., 2001; Valasek et. al., 
2002; Valasek et. al., 2003; Olsen et. al., 2003; Nielsen et. al., 2004; Singh et. 
al., 2005).  In the next step, eIF4F, which is composed of factors eIF4A, eIF4E, 
and eIF4G (Hernandez and Vazquez-Pianzola, 2005) facilitates interaction of the 
43S pre-initiation complex with the 5‟ cap structure of the mRNA producing the 
48S pre-initiation complex.  Efficient formation of the 48S pre-initiation complex is 
also dependent on eIF3 (Hinnebusch et. al., 2004).  The 40S complex scans the 
mRNA from the 5‟ end for the start codon in a process mediated by eIF1 and 
eIF1A (Maag et. al., 2005).  Once the Met-tRNAi anti-codon pairs with the AUG 
codon, eIF2-bound GTP is hydrolyzed in a reaction stimulated by eIF5 (Das and 
Maitra, 2000).  The GTP hydrolysis triggers the release of the bound eIFs and 
the joining of the 60S subunit to create the 80S ribosome (Das and Maitra, 2001).  
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At this point, the 80S complex accepts the next aminoacyl-tRNA in the A site of 
the ribosome and the process of translation elongation begins. 
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Figure 1-1 Translation Initiation in Eukaryotic Cells. Adapted from Gebauer, 
et. al. Nat Rev Mol Cell Biol. 2004, 5(10):827-35   
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 Elongation is the process by which the ribosome decodes 
polypeptide information from the codons of the mRNA to produce the nascent 
polypeptide by utilizing the ribosome‟s peptidyl transferase activity.  The 
ribosome scans down the template mRNA and base pairs the appropriate 
anticodon of a charged aminoacyl-tRNA with the cognate mRNA codon.  The 
23S rRNA within the 60S subunit catalyzes peptide bond formation (Jackson et. 
al., 2010).  The process of elongation is mediated by two key proteins.  eEF1A is 
responsible for delivering cognate aminoacyl-tRNAs to the A-site of the 
ribosome.  Once in position, the nascent peptide chain is transferred to the amino 
acid of the A-site aminoacyl-tRNA.  The second factor, eEF2 is involved in 
translocating both mRNA and tRNA from the A-site to the P-site following 
peptidyl transfer.  eEF2 then promotes the transfer of deacylated tRNA from the 
P-site to the E-site.  Yeast and various other fungi possess an additional 
elongation factor, eEF3, which is required for elongation and contains ribosome 
stimulated ATPase activity.  eEF3 interacts with both ribosomal subunits and 
facilitates eEF1A-mediated cognate aminoacyl tRNA binding to the ribosomal A-
site. 
The final step in the process of translation is termination and involves 
recognition of the stop codon, mRNA release and dissociation of the 80S 
ribosome into 40S and 60S subunits.  When a UAA, UAG or UGA stop codon 
enters the A-site, the release factor eRF1 recognizes the stop codon (Kisselev et. 
al., 2003).  eRF3 then hydrolyzes the ester bond of the P-site peptidyl-tRNA 
(Alkalaeva et. al., 2006).  eRF1 is composed of three distinct functional domains.  
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Domain 1 is believed to recognize stop codons in the A-site of the ribosome 
(Song et. al., 2000).  Domain 2 interacts with the peptidyl transferase center of 
the ribosome to trigger peptidyl-tRNA hydrolysis by eRF3 (Frolova et. al., 1999).  
The final domain is thought to mediate eRF3 binding to eRF1 (Ito et. al., 1998). 
In eukaryotes, the regulated translation of mRNAs, or translational control, 
is a major regulatory mechanism involved in all biological processes, including 
development (de Moor et. al., 2005), response to stress (Hinnebusch, 2005; 
Holcik and Sonenberg, 2005; Clemens, 2005), signaling (Parsa and Holland, 
2004; Shmulevitz et. al., 2005), plasticity (Sutton, 2005), immune response 
(Lindemann, 2005; Beretta, 2004), and cell growth (Kuersten and Goodwin, 
2003; Gebauer and Hentze, 2004).  Defects in protein synthesis and translational 
control are major factors in diseases, including fragile-X syndrome (Denman et. 
al., 2004) and several different cancers (Bjornsti and Houghton, 2004; Ruggero 
and Sonenberg, 2005).  Multiple drug therapies are being developed and used to 
treat human diseases that focus on the translation machinery (Meric and Hunt, 
2002).  One example is the chemotherapeutic drug rapamycin, which targets the 
TOR signaling pathway involved in regulating translation (Calkhoven et. al., 
2002; Tee et. al., 2005).  
Specific regulatory events, namely protein phosphorylation of eIFs serve 
to both increase and decrease their activities within cells.  Phosphorylation of the 
eIF2 subunit of eIF2 blocks the exchange of GDP for GTP by eIF2B.  This 
prevents the formation of the 43S preinitiation complex and inhibits protein 
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synthesis (Hinnebusch, 1997).  Phosphorylation of eIF4 has been shown to 
correlate with increased translation rates (Sonenberg, 1997).  In addition, 
phosphorylation of the eIF4E binding protein (4E-BP) inhibits its ability to bind 
eIF4E and results in an increase in translation rates (Figure 1-1) (Gingras et. al., 
2001).  Dephosphorylation of 4E-BP has been shown to occur under nutrient 
starvation and cellular stress (Gingras et. al., 2001). 
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Figure 1-2.  Phosphorylation of eIFs altering their activity levels.  Previous 
investigations have established that eIF3 activity is regulated in response to cellular 
stimuli.
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The role of the eIF3 complex 
 Translation initiation in eukaryotes is dependent on the concerted actions 
of a multitude of eIFs (Figure 1-1).  At least 12 different eIFs function to interact 
with Met-tRNA, mRNA, and the ribosomal subunits to form pre-initiation 
complexes and recognize the AUG start codon on mRNA (Hinnebusch, 2005).  
eIFs are regulated by a variety of cellular responses to control gene expression 
(Hinnebusch, 2000).  One of the first eIFs to be identified was eIF3, but until 
recently, its functional roles remained unknown.  eIF3 has been implicated to 
have a role in the assembly of the ternary complex composed of eIF2, GTP, and 
Met-tRNA (Valasek et. al., 2002).  eIF3 also recruits the ternary complex along 
with the 40S ribosomal subunit to form the 43S preinitiation complex and further 
functions to scan along the mRNA for AUG start codon recognition.  Table 1-1 
shows the compositional variation of eIF3 among a variety of organisms 
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Subunit 
Name 
Gene 
Name 
Human 
MW 
S. 
cerevisiae 
MW 
S. pombe 
MW 
Wheat 
MW 
A. thaliana 
MW 
eif3a RPG1 170 110 107 116 114 
eif3b PRT1 116 90 84 83 82 
eif3c NIP1 110 93 104 107 105 
eif3d MOE1 66 none 63 87 66 
eif3e INT6 48 none 57 45 51 
eif3f CSN6 47 none 33 34 32 
eif3g TIF35 44 33 31 36 33 
eif3h  40 none 40 41 38 
eif3i TIF34 36 39 37 41 36 
eif3j HCR1 35 30 31 none none 
eif3k  28 none none 25 25 
eif3l  none none none 60 60 
 
Table 1-1.  The composition of eIF3 in various organisms. 
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 eIF3 in the budding yeast S. cerevisiae is composed of five core proteins, 
Rpg1, Nip1, Prt1, Tif34, and Tif35, all of which are essential genes (Phan et. al., 
1998) (Figure 1-3).  The largest of these proteins, Rpg1, was initially identified as 
a required protein for yeast to pass through G1 phase (Kovarik et. al., 1998).  
Rpg1 was identified as part of eIF3 due to its homology with a subunit of the 
mammalian eIF3.  A study of Rpg1 has shown that deletion of the N-terminal 
domain impairs 40S subunit binding (Nielsen et. al., 2006).  Prt1 was initially 
identified in yeast as required factor for translation initiation and cellular 
proliferation (Hanic-Joyce et. al., 1987).  It has also been shown that the N-
terminal domain of Prt1 contains a RNA recognition motif that mediates a protein-
protein interaction with Hcr1.  This is unique in that the RNA binding domain of 
Prt1 has dual functionality as a protein binding domain (Valasek et. al., 2001).  
Both the RNA binding domain and the Hcr1 interaction are necessary for eIF3 to 
bind the 40S ribosome.  In addition, mutations in Prt1 reduce eIF3‟s ability to bind 
Met-tRNA (Phan et. al., 1998).  When both Rpg1 and Prt1 are separately 
depleted in yeast, recruitment of the mRNA to the 40S subunit is greatly impaired 
(Jivotovskaya et. al., 2006).  Nip1, initially identified as a nuclear transport 
protein, has since been shown to be part of the eIF3 complex (Gu et. al., 1992; 
Valasek et. al., 2000).  Studies have determined that Nip1 interacts with 
ribosomal 40S subunit proteins Rps0A and Rps10A and may directly contact the 
solvent-exposed side of the 40S subunit (Valasek et. al., 2003).  Mutations in 
Nip1 cause faulty AUG start codon selection (Valasek et. al., 2004). Tif34 and 
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Tif35 have been shown to promote the linear scanning of mRNA (Cuchalova et. 
al., 2010). 
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Figure 1-3.  The multifactor complex (MFC).  Through the concerted action of 
eIFs and associated proteins, the MFC functions to form the 48S preinitiation 
complex.  Adapted from Valasek, et al., Genes and Development, 2003, 17:786-
799. 
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Proteomic analysis of protein complexes 
A comprehensive understanding of protein synthesis control mechanisms 
is absolutely essential to understanding both normal and disease-altered cellular 
processes.  Identification of all the proteins involved in translation will be a key 
step towards dissecting the molecular mechanisms of eukaryotic protein 
synthesis.  Mapping the interactions and posttranslational modifications of these 
proteins will provide insights into their biochemical functions and regulation.  The 
identification of novel translation initiation factors and regulatory modifications 
may lead to new molecular targets for therapeutic intervention in a number of 
human diseases.  Given the high percentage of genes in the genomes of 
sequenced organisms are uncharacterized, I hypothesize that unexpected 
proteins are associated with eukaryotic eIF3 translation complexes. To identify 
novel protein interactions, I performed a systematic and targeted tandem affinity 
purification (TAP) purification and mass spectrometry analysis.    Several studies 
have reported the results of large-scale, systematic affinity purifications of yeast 
proteins of various functions and processes followed by mass spectrometry 
analysis (Gavin et. al., 2002; Ho et. al., 2002; Krogan et. al., 2004; Gavin et. al., 
2006). In contrast to there earlier studies, my focused project used replicate 
analysis and semi-quantitative approaches to quantify the abundance of 
identified proteins from the mass spectrometry analysis of the affinity purified 
protein complexes.      
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Of the techniques currently available for determining protein interaction 
networks, mass spectrometry-based (MS) proteomics is perhaps the most 
powerful.  The term proteomics refers to the analysis of all the proteins in a 
biological sample including posttranslational modifications and alternatively 
spliced variants of proteins (Wilkins et. al., 1996).  Since this term was coined in 
1995, it has evolved to include protein expression, function, structure, and sub-
cellular localization (Graves and Haystead, 2002; Pandey and Mann, 2000; 
Aebersold and Mann, 2003).  The key instrument utilized in proteomics today is 
the mass spectrometer.  The developments in the technology and methodology 
associated with this instrumentation have improved dramatically in the past 25 
years (Qoronfleh, 2006).  Some of these advents include both electrospray 
ionization (ESI) and matrix assisted laser desorption ionization (MALDI) to 
generate charged species for MS analysis, as well as new MS instrumentation 
with a marked increase in sensitivity, resolution, and accuracy.  The great 
complexity of the proteome necessitates additional technology to resolve protein 
mixtures prior to mass spectrometry.  This was originally approached using two-
dimensional gel electrophoresis to separate proteins based upon molecular 
weights and isoelectric points.  However, this technique is slow, inconsistent, and 
limited by the physical properties of the proteins analyzed but allows the analysis 
of intact proteins (Zhou and Johnston, 2004).  Another two-dimensional method 
uses isoelectric focusing to fractionate proteins based on their isoelectric points.  
The fractions are then collected and can be subjected to another round of 
separation based on another dimension using reverse phase separation or size 
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exclusion.  A similar approach is the basis of Proteome Discovery‟s GELFREE 
system.  In this approach proteins are fractionated using a SDS-PAGE gel for the 
first dimension which can be further fractionated for more comprehensive 
separations.  To circumvent the problems associated with 2D gels, new 
techniques have been developed that utilize chromatographic separations of 
whole proteins or peptides from proteolytically digested proteins. 
 Two methods are typically used to generate protein and peptide ions for 
MS analysis.  The first, electrospray ionization (ESI), generates ions from a liquid 
stream passed through a voltage difference.  This technique easily adapts to 
online liquid chromatography (LC).  The ions generated by ESI are multiply 
charged, thereby serving to increase the mass range of the MS instrument and 
enabling the use of quadrupole mass analyzers.  It was shown in 1989 that a 
triple quadrupole instrument could be used to fragment the multiply charged ions 
of intact peptides generated by ESI (Hunt et. al., 1989).  From this fragment 
information, it is possible to generate spectra that can be analyzed to yield amino 
acid sequence information.  This development promoted work that combined 
tandem mass spectrometry (MS/MS) with online LC through ESI to generate 
peptide sequence information on complex peptide mixtures (Covey et. al., 1991).  
However, LC-ESI is best suited to small, acidic peptides and is restricted by the 
online nature of the chromatography.  Tandem spectra are typically generated in 
a data-dependent manner on the most intense ions reaching the detector.  The 
data dependency arises in that the instrument generally selects an nth most 
intense ion from the initial precursor scan for fragmentation and subsequent 
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detection in the tandem mass spectrum.  As a result, only a subset of available 
spectra is generated for every data-dependent cycle.  Additionally, co-elution of 
peaks in the chromatography will cause suppression of the less intense signal 
and loss of data.  There also exists a finite time to gather data as a peak is eluted 
from the chromatography column. 
 The second major method for ionization, MALDI, involves mixing peptides 
with a matrix material, typically cinnamic acid derivatives (Gobom et. al., 2001).  
The matrix serves to absorb energy in the form of electromagnetic radiation 
applied to the matrix-sample mixture.  The absorbed energy causes the 
ionization of the sample-matrix which then passes to the mass analyzer.  MALDI 
was originally utilized in the field of proteomics for peptide mass fingerprint 
analysis of digested proteins.  This ionization technique is best suited to large, 
basic peptides as opposed to those generated by ESI, and MALDI produces 
singly charged ions that have greatly simplified spectra.  Since MALDI requires 
an offline method of separating peptides it was easily amenable to 2D-gel based 
applications.  The offline nature of generating MALDI samples allows this 
approach to overcome some of the temporal limitations associated with online LC 
methods.   
 The traditional liquid chromatography-based (LC) separation for MS/MS 
analysis involves strong cation exchange (SCX), strong anion exchange (SAX), 
or reverse phase (RP) in a single dimension.  The dimensionality of the 
chromatography refers to the steps used to separate peptides.  For example, a 2-
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D separation would consist of using a reverse phase material to separate based 
upon hydrophobicity and then a SAX resin to fractionate based upon charge.   
Only separating proteins or peptides in one-dimension causes an abundant 
overlap of elution peaks in the chromatogram leading to obscuring and 
subsequent signal loss.  To circumvent this problem, the multidimensional 
peptide identification technology (MudPIT) method was developed (Link et. al., 
1999).  MudPIT consists of a biphasic column containing a SCX section followed 
by RP material.  This 2D configuration, when combined online with ESI-MS/MS, 
resulted in the most complete proteome characterization of the yeast S. 
cerevisiae at its time with the identification of 1,484 proteins (Washburn et. al., 
2001).  It is now possible to add an additional dimension to the MudPIT analysis 
to further fractionate complex samples (Washburn, 2002).  
Proteomic analysis of posttranslational modifications 
 Protein posttranslational modifications (PTMs) perform essential roles in 
the biological regulation of a cell (Rucker and McGee, 1993). PTMs are 
enzymatic, covalent chemical modifications of proteins that typically occur after 
translation from mRNAs. Chemical modifications of proteins are extremely 
important because they potentially change a protein‟s physical or chemical 
properties, conformation, activity, cellular location, or stability. In fact, most 
proteins are altered by the addition or removal of a chemical moiety on either the 
functional group of an amino acid or the protein‟s N- or C-terminus. Some PTMs 
can be added and removed dynamically as a mechanism for reversibly 
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controlling protein function. Over 420 types of protein modifications have been 
identified and curated in the UNIPROT database to date (www.uniprot.org). The 
most commonly identified PTMs to date include phosphorylation, sumoylation, 
ubiquitination, nitrosylation, methylation, acetylation, sulfation, glycosylation, and 
acylation (Table 1-2). 
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PTM Nominal Mass shift (Da) Stability Proposed biological function 
Phosphorylation 
          pSer, pThr 
          pTyr 
 
+80 
+80 
 
Very labile 
Moderately labile 
Cellular signaling processes, 
enzyme activity, intermolecular 
interactions 
Glycosylation 
          O-linked 
          N-linked 
 
203, >800 
>800 
 
Moderately labile 
Moderately labile 
 
Regulatory elements, -GlcNAc 
Protein secretion, signaling 
Proteinaceous 
          Ubiquitination 
          Sumoylation 
 
>1,000 
>1,000 
 
Stable 
Stable 
 
Protein degradation signal 
Protein stability 
Nitrosative 
          Nitration, nTyr 
          Nitrosylation, 
                    nSer, nCys 
 
+45 
+29 
 
Stable 
Stable 
 
Oxidative damage 
Cell signaling, enzyme activity 
Methylation +14 Stable Transcription 
Acetylation +42 Stable Histone regulation, protein 
stability 
Sulfation, sTyr +80 Very labile Intermolecular interactions 
Deamidation +1 Stable Intermolecular interactions, 
sample handeling artifact 
Acylation 
          Farnesyl 
          Myristoyl 
          Palmitoyl 
 
+204 
+210 
+238 
 
 
Stable 
Stable 
Moderately labile 
Membrane tethering, 
intermolecular interactions, cell 
localization signals 
Disulfide bond -2 Moderately labile Protein structure and stability 
Alkylation ,aCys +57 Stable Sample handeling 
Oxidation, oMet +16 Stable Sample handeling  
Table 1-2.  Common PTMs encountered in mass spectrometry.  Included are their 
associated mass shifts, predicted MS stability and proposed biological functions. 
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Vast amounts of scientific effort have gone toward identifying PTMs and 
elucidating their biological functions. Perhaps the best studied cases involve 
eukaryotic histones and the myriad of PTMs that are associated with 
transcriptional regulation (Berger, 2007; Fuchs et al., 2009; Issad and Kuo, 2008; 
Olsson et al., 2007; Reid et al., 2009). Histones associate with chromosomal 
DNA to form nucleosomes that bundle together to form chromatin fibers. The 
histone code hypothesizes that chromatin–DNA interactions are regulated by 
combinations of histone PTMs (Jenuwein and Allis, 2001; Strahl and Allis, 2000). 
The acetylation of lysine was first discovered in histones and is correlated with 
actively transcribed genes (Roth et al., 2001). Combinations of methylation, 
acetylation, ADP ribosylation, ubiquitination, and phosphorylation of histone tails 
function to regulate specific gene expression programs (Godde and Ura, 2008). 
One of the most ubiquitous PTMs, phosphorylation, is the focus of many 
biochemical investigations. It has been estimated that 30% of the human 
proteome is phosphorylated (Cohen, 2001; Hubbard and Cohen, 1993). For 
example, tyrosine kinases and phosphatases transduce signals from ligand-
bound receptors on the cell surface to downstream targets in the insulin/IGF-1 
signaling pathway (Taniguchi et al., 2006). Classic approaches to detecting 
PTMs on proteins involved Edman degradation and thin-layer chromatography 
(TLC). However, these methods are hampered by the requirement of significant 
amounts of starting material and an inability to identify rare or substoichiometric 
PTMs. Because most PTMs result in a concomitant change in the mass of the 
modified protein, methods that can detect changes in molecular mass, namely 
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mass spectrometry-based proteomics, are now routinely utilized to identify PTMs. 
Some PTMs, such as phosphorylation or methylation, increase the mass of a 
protein, while other PTMs, like signal peptide cleavage or disulfide bond 
formation, decrease the mass. Depending on the mass spectrometry instrument 
used, the proteomic approaches have the advantage of high sensitivity and can 
determine molecular masses to an accuracy of less than 1 part per million (<1 
ppm) (Makarov et al., 2006; Lu et al., 2008; Scigelova and Makarov, 2006).  
Instrument manufacturers and academic researchers are constantly 
improving instrument technologies and developing new methods to identify PTMs 
(Garcia et al., 2007). For example, recent advances in the field include such 
developments as electron transfer dissociation (ETD) and electron capture 
dissociation (ECD) for the chemical fragmentation of peptides and dynamic 
detectors capable of accurately measuring masses of undigested proteins (Coon 
et al., 2004; Mikesh et al., 2006; Pitteri et al., 2005; Syka et al., 2004). 
Enrichment strategies to selectively isolate proteins or peptides with a desired 
PTM can be coupled with mass spectrometry-based proteomic techniques. 
These enrichment techniques can alleviate the problems created by rare 
modifications. Among the variety of affinity enrichment strategies available, there 
are two major categories. First are approaches that use antibodies to recognize a 
specific PTM or uniquely modified peptide. For example, antiphosphotyrosine 
antibodies are used to enrich for peptides with phosphotyrosine residues 
(Blagoev et al., 2004; Rush et al., 2005; Zhang et al., 2005). Second, there exist 
emerging technologies to enrich for PTMs based on the chemical affinity of a 
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modification for an immobilized resin. Such techniques include immobilized metal 
affinity chromatography (IMAC) for phosphorylations and lectin chromatography 
for glycosylations (Ito et al., 2009). 
Another widely used proteomic technique useful in the identification of 
PTMs is two-dimensional gel electrophoresis (2D-GE). PTMs can alter the 
isoelectric point and electrophoretic mobility of a protein in a 2D-gel experiment. 
When such a change is detected between different cell types or growth 
conditions, the protein can be isolated and sequenced to identify its PTMs. For 
example, the differential phosphorylation of a protein will alter its isoelectric point 
and may cause charge heterogeneity. The differentially phosphorylated protein 
will appear as a train of 2D spots with different isoelectric points but with similar 
molecular weights. This pattern is sometimes referred to as „„pearls-on-a-string.‟‟ 
Specific protein staining methods for revealing protein PTMs have been devised 
over the years (Ge et al., 2004; Patton, 2002). These include fluorescent 
methods for the direct detection of phosphoproteins and glycoproteins in gels 
(Ge et al., 2004; Steinberg et al., 2001; Schulenberg et al., 2003). For these 2D 
spots, the proteins can be in-gel digested, and the recovered peptides can be 
analyzed by mass spectrometry to identify, validate, and map the expected PTMs 
(Hayduk et al., 2004; Steinberg et al., 2003). However, the 2D-GE approaches to 
identifying PTMs are not trivial since the recovery and analysis of the modified 
peptides are often problematic. 
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Multiple tools now exist in proteomics to quantify the absolute or relative 
abundance of proteins and their specific PTMs (Paoletti and Washburn, 2006). In 
vivo and in vitro labeling methods have been developed to use mass 
spectrometry for quantifying PTMs and precisely measuring their changes during 
cellular events (Goodlett et al., 2001; Gygi et al., 1999; Oda et al., 1999; Ong et 
al., 2002; Ross et al., 2004; Zhang et al., 2005).  Quantitation can be crucial in 
determining the biological significance of a given PTM, since simply identifying 
the presence of a modification will not provide sufficient biological information to 
model its importance. A study by Matthias Mann and coworkers performed in 
HeLa cells found that 14% of the identified phosphorylation sites were modulated 
at least two fold by epidermal growth factor stimulation, demonstrating the 
importance of quantifying PTMs (Olsen et al., 2006). 
There are, however, several limitations that must be considered when 
using mass spectrometry-based proteomics to identify PTMs. Some PTMs, such 
as phosphorylation of serine, tyrosine and threonine, and either O-linked or N-
linked glycosylation, are labile, and maintaining the modification during sample 
preparation can be difficult. If ineffective separation techniques are used, 
unmodified peptides or proteins can mask the modified form during the mass 
spectrometry analysis. The detection of substoichiometric PTMs is especially 
difficult when the majority of the protein molecules may be unmodified. Proteins 
are typically digested into peptides, and the peptides are directly analyzed. 
Modification of a given peptide with labile groups such as in phosphorylation, 
sulfation, and glycosylation can reduce its ionization efficiency, thereby 
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compromising the mass spectrum and preventing sequence determination. 
Alternatively, there can be ambiguity as to which amino acid is modified, since 
many peptides contain multiple potential amino acid targets for the PTM. In 
addition, when using collision induced dissociation (CID) to fragment peptides 
containing labile PTMs such as phosphorylation and glycosylation, the labile 
group undergoes a -elimination reaction to generate a neutral loss fragment 
(Figure 1-2). This pathway is more energetically favorable than fragmentation at 
the amide bonds. The resulting mass spectrum often fails to generate enough 
sequencing ions to unambiguously identify the peptide or modified amino acid. 
Finally, the detection of rare PTMs can be challenging, and identification often 
requires highly sensitive mass spectrometry methods or PTM enrichment 
strategies. 
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Figure 1-4.  -elimination of H3PO4.  Labile functional groups added to amino 
acid side chains can undergo the more energetically favorable elimination 
reaction to generate an alkene and phosphoric acid.  X=H for serine and X=CH3 
for threonine. 
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Phosphorylation 
 The reversible phosphorylation of serine, threonine, and tyrosine residues 
is probably the most heavily studied PTM. Protein phosphorylation signaling 
networks mediate cellular responses to a variety of stressors, growth factors, 
cytokines, and cellular interactions. Phosphorylation also influences a multitude 
of cellular processes such as proliferation, proteolysis, apoptosis, migration, 
transcription, and protein translation (White, 2008). Phosphorylation events have 
the ability to force conformational changes in a protein‟s structure that can either 
activate or deactivate the protein‟s enzymatic activity.  Phosphate groups are 
polar in nature and when added to residues, decrease the hydrophobicity of their 
environment.  In eukaryotic cells, reversible protein phosphorylation occurs 
primarily on serine, threonine, and tyrosine side chains.  However, S. cerevisiae 
lack tyrosine kinases and phosphorylation is primarily restricted to serines and 
threonines.  Aberrant regulation of protein kinases and phosphatases has been 
implicated in cancer, autoimmune diseases, metabolic disorders, and infectious 
diseases (Blume-Jensen and Hunter, 2001; Gatzka and Walsh, 2007; Sirard et 
al., 2007; Taniguchi et al., 2006). Single phosphorylation events can have 
dramatic implications on cellular processes. For example, the dephosphorylation 
of eIF4E-binding protein is triggered by nutrient deprivation, environmental 
stress, or infection with some picornaviruses and results in a marked increase in 
eIF4E binding activity and an inhibition of translation (Gingras et al., 2001). 
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The traditional method of identifying phosphorylation sites involves 
growing cells with 32P-labeled ATP or phosphoric acid. The phosphoproteome 
incorporates the radioactive phosphate from the growth medium. The radioactive 
proteins are detected using such techniques as 2D-GE or high-performance 
liquid chromatography (HPLC). The fractionated proteins are then isolated and 
hydrolyzed. The resulting phosphopeptides are separated on TLC plates and 
subsequently sequenced by Edman degradation. However, these techniques are 
time consuming, require large amounts of relatively pure phosphoproteins, and 
necessitate the use of significant amounts of radioactive material (McLachlin and 
Chait, 2001). Because of these drawbacks, mass spectrometry-based 
proteomics has quickly emerged as the preferred technique for identifying 
phosphorylations. 
 A proteomic study comparing Escherichia coli, Lactococcus lactis, and 
Bacillus subtilis found that nearly every enzyme in the glycolytic pathway, which 
mediates carbon metabolism, was phosphorylated on various serine, threonine, 
and tyrosine residues (Soufi et al., 2008). Interestingly, they also found that the 
detected consensus sites of phosphorylation appear far more evolutionarily 
conserved than the primary sequence (Soufi et al., 2008). A separate study 
investigating the mouse liver phosphoproteome identified many of the 
phosphorylation sites previously annotated in the Swiss-Prot mouse database 
(Pan et al., 2008). However, more than half of the identified sites were novel, 
suggesting that there are still many more phosphorylation sites yet to be 
identified in the mouse phosphoproteome (Pan et al., 2008). 
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Mass spectrometers have the ability to identify specific sites of 
phosphorylation within complex protein mixtures. This approach does present 
problems that are often faced in other proteomic applications, including limited 
sample amounts, complex samples, and a wide dynamic range of protein 
concentrations within the sample (White, 2008). To compound the difficulty of 
these experiments, phosphorylation is often substoichiometric, and therefore the 
phosphopeptide is at a lower concentration than the other peptides from the 
same protein. The large population of unmodified peptides suppresses the mass 
spectrometric response to the phosphopeptides. This phenomenon can lead to a 
lack of detectable signal for the phosphopeptides of interest (McLachlin and 
Chait, 2001). Suppression artifacts can be minimized by reducing the fraction of 
unmodified peptides relative to the PTM variants using any of a variety of 
enrichment strategies. One such enrichment strategy applicable to identifying 
phosphorylations is the use of strong cation exchange (SCX) resin to selectively 
isolate phosphopeptides.  It has been found that, with a pH of less than 2.6, 
tryptic phosphopeptides are not retained by the SCX particles (Beausoleil et al., 
2004). This is likely due to their more anionic nature afforded by the phosphate 
group. The flow through of the SCX column can be subsequently fractionated 
with a reverse phase (RP) column and subjected to mass spectrometry analysis 
(Lim and Kassel, 2006). The separation of the phosphorylated peptides from their 
unmodified counterparts helps alleviate the problem of suppression during mass 
spectrometry as discussed above. This enrichment strategy has the advantage of 
being applicable to both off-line and on-line fractionation approaches. One 
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negative aspect of this approach is that it relies on the inability of the SCX resin 
to bind the phosphopeptides, as opposed to other strategies that bind the 
phosphorylated residues and thereby positively enrich for them selectively.   
Immobilized Metal Affinity Chromatography (IMAC) is the most widely 
utilized method for selectively isolating phosphopeptides from complex mixtures 
of digested proteins. This method typically utilizes a metal chelating agent to bind 
trivalent metal cations, such as Fe3+ or Ga3+ (Sykora et al., 2007). The charged 
resin is subsequently used to bind the phosphorylated peptides. The resin with 
bound phosphopeptides is washed with a rinse solution, typically an acetic acid 
solution, to remove unmodified peptides. The phosphopeptides can then be 
eluted with phosphate buffer or a high pH solution either directly onto a RP 
column for desalting and subsequent mass spectrometric analysis or off-line for 
further enrichment or manipulation. The IMAC approach does present some 
complications, however. If multiply phosphorylated peptides are present in 
abundance, they can overwhelm the IMAC resin and result in the loss of singly 
and doubly phosphorylated species. Additionally, other acidic peptides will have 
an affinity for the IMAC column and will be enriched along with the 
phosphorylated peptides. This problem is exacerbated by exceedingly complex 
peptide mixtures such as whole cell extracts. In an attempt to avoid this problem, 
many investigators methyl esterify the acidic residues and the C-terminus using a 
chemical reduction procedure (Ficarro et al., 2002). However, studies have found 
that the methyl esterification reaction is not quantitative (Cirulli et al., 2008). 
Thus, the peptide of interest is present as modified, partially modified and 
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unmodified versions. The complexity of the mixture is increased, and the relative 
amount of a given peptide is actually reduced (Cirulli et al., 2008). 
An approach analogous to IMAC is the use of titanium dioxide (TiO2) as a 
substitute for the metal chelating resin (Larsen et al., 2005; Pinkse et al., 2004; 
Thingholm et al., 2006). Just as the phosphate groups of the modified peptides 
have affinity for the trivalent metal used in IMAC, they also have an affinity for the 
titanium dioxide molecules under acidic conditions (Larsen et al., 2005; Pinkse et 
al., 2004; Thingholm et al., 2006). By shifting to a high pH buffer, the 
phosphopeptides can be eluted from the TiO2 material. This approach has the 
advantage of requiring less column preparation time and fewer rinse cycles than 
the IMAC resin. Studies have shown that, although these two methods use the 
same principle of affinity, they are complementary in that distinct 
phosphopeptides are detected by each of the two approaches (Cantin et al., 
2007). IMAC is characterized by a higher affinity for multiply phosphorylated 
peptides while titanium dioxide preferentially binds singly phosphorylated species 
(Bodenmiller, et al., 2007). This highlights the utility of using both approaches in 
a single investigation to obtain maximal coverage of the phosphoproteome.  
Another method for phosphopeptide enrichment employs chemically 
introduced affinity tags at the sites of phosphorylation (Goshe et al., 2001; Oda et 
al., 2001). One such method uses an alkaline environment to remove H3PO4 
from phosphoserine or phosphothreonine residues in a -elimination reaction 
(McLachlin and Chait, 2003; Oda et al., 2001).  A dithiol group is then added to 
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the double bond in a Michael-like addition reaction. The thiol is then treated with 
an alkylating reagent linked to a biotin group. The resulting biotinylated peptides 
can then be enriched using avidin column chromatography (McLachlin and Chait, 
2003).  One difficulty of this approach is the recovery of the tagged species can 
be problematic due to the high affinity of biotin for avidin. Also, this method 
enriches for phosphoserine and phosphothreonine, not phosphotyrosine. O-
linked -N-acetylglucosamine (O-GlcNAc) modifications are also susceptible to -
elimination followed by Michael addition and can therefore compete with 
phosphorylations for enrichment (Wells et al., 2002). Finally, under the alkaline 
environment of the -elimination reaction, unwanted side reactions can occur that 
have unanticipated affects on peptide mass. These side reactions can make it 
difficult to identify the peptides downstream during mass spectrometry. 
During mass spectrometry, specific chemical properties of 
phosphoproteins must be taken into account. Phosphorylation is a labile addition 
to S and T amino acids. Traditional fragmentation methods result in the 
preferential neutral loss of H3PO4 or HPO3 from phosphoserine and 
phosphothreonine residues prior to fragmentation along the peptide backbone. 
The vast majority of the population undergoes -elimination reaction, leaving only 
a fraction remaining to fragment along the backbone (Bennett et al., 2002; Lee et 
al., 2001; Ma et al., 2001). The resulting mass spectrum contains fewer 
sequencing ions, and these ions are generally lower in intensity. Therefore, there 
is a low signal-to-noise ratio, which hampers interpreting the peptide sequence. 
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 Although capable of losing the phosphate group, phosphotyrosine seldom 
generates the intense neutral loss ions that are seen for peptides containing 
phosphoserine or phosphothreonine residues. Some mass spectrometers that 
use electron transfer dissociation (ETD) or electron capture dissociation (ECD) 
avoid this neutral loss problem and can yield spectra suitable for both sequence 
analysis and phosphoresidue determination. This alternative fragmentation 
method will be discussed further when considering the various instrument types 
used in the proteomic identification of PTMs. On the other hand, neutral loss 
artifacts can be used to the advantage of the investigator. The neutral loss 
signature is a conspicuous indicator that the peptide contains a site of 
phosphorylation. The neutral loss peak observed in the mass spectrum is 
generally of high intensity due to its preferential formation. Therefore, if a loss of 
98 m/z (H3PO4) or 80 m/z (HPO3) for a +1 charged peptide is observed from the 
precursor ion, one can infer the presence of a phosphoserine or 
phosphothreonine reside within the sequence of the peptide. Modern mass 
spectrometers can monitor for this mass loss. An ion trap mass spectrometer can 
isolate the neutral loss species and initiate another round of fragmentation (MS3 
scan) (Beausoleil et al., 2004; Gruhler et al., 2005; Olsen and Mann, 2004; Ulintz 
et al., 2009). This additional analysis step can result in additional sequence 
coverage to aid in identifying the phosphopeptides and mapping the PTM to a 
specific amino acid. An alternative approach to an MS3 scan is „„Pseudo MSn‟‟ or 
multistage activation (MSA) for phosphopeptide fragmentation in an ion trap 
mass spectrometer (Schroeder et al., 2004). The method induces CID of the 
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neutral loss product from the MS/MS scan of the phosphopeptide. The product 
ions from the neutral loss ions along with the initial MS/MS product ions are 
trapped together resulting in a composite spectrum. In MSA, the neutral loss 
product ions are converted into a variety of structurally informative fragment ions, 
which show improved scores in database search algorithms (Schroeder et al., 
2004; Ulintz et al., 2009).  
Phosphorylation introduces a negative charge onto the peptide, and this 
also can affect analysis by mass spectrometry. The negative charge can reduce 
the mass spectrometer response when operated in positive-ion mode (McLachlin 
and Chait, 2001). This diminished response results in poor quality spectra and 
makes identifying the phosphopeptide more difficult. Furthermore, this increased 
negative charge can reduce proteolysis during preparation of protein mixtures 
prior to mass spectrometry. As a caveat, Hanno Steen and coworkers found no 
evidence for decreased ionization/detection efficiencies when selectively 
investigating phosphopeptides using electrospray ionization (ESI) (Steen et al., 
2006). As an alternative, a precursor ion scanning technique pioneered by Steve 
Carr and coworkers can be employed to avoid some of the problems generated 
by performing MS in the positive-ion mode (Carr et al., 1996). Tandem mass 
spectrometry is performed in negative-ion mode, and phosphorylated residues 
generate characteristic fragments of 79 Da for PO3 or 63 Da for PO2. When one 
of these events is detected in the precursor ion scan, MS/MS is performed on the 
precursor ion (Zappacosta et al., 2006). This approach can be more sensitive 
than positive mode mass spectrometry for detecting phosphopeptides (Carr et 
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al., 1996). However, negative-mode spectra are difficult to interpret and not 
widely studied (Witze et al., 2007). One interesting approach combines both 
positive-ion mode and negative-ion mode in the same experiment. Precursor ion 
scanning is performed in the usual negative ion mode, the instrument‟s polarity is 
switched, and MS/MS fragmentation spectra are obtained in the positive-ion 
mode (Carr et al., 1996). Although identifying sites of phosphorylation is 
challenging, many proteomic techniques are available that can be customized for 
characterizing these critically influential PTMs. 
Protein and PTM quantitation 
 When investigating the biological significance of PTMs, it is often 
advantageous to know the relative or absolute abundance of a specific 
modification or group of PTMs. This allows for the direct comparison of the 
modification of interest across varied biological samples. An example is 
comparing the abundance of a PTM in cells or tissues obtained from a normal 
versus a disease state. Quantifying these changes can lead to insights into the 
role of PTMs in a myriad of processes from cell growth to diseases and 
apoptosis. A range of methods are available to quantify PTMs. Traditional 
methods utilize 2D-GE and differential staining to identify differences in the level 
of protein expression among samples. However, this approach has a low 
resolution and sensitivity, and differences in the ability of some proteins to stain 
can lead to artifacts (Ong and Mann, 2005). The 2D-GE approach is most 
amenable to abundant protein species (Anderson and Anderson, 1998). More 
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recently, mass spectrometry-based approaches have alleviated some of the 
problems posed by gel-based approaches. These methods include protein or 
peptide labeling strategies, tagging approaches and differential proteomic 
methods using spectral counting (Gygi et al., 1999; Ong et al., 2002; Washburn 
et al., 2001). While these methods are more widely applied to quantifying protein 
changes among samples, they can also be used to quantify changes in PTMs 
from different biological samples.   
Quantitative measurements can either be absolute, in terms of 
concentration or copy number per cell, or relative, in terms of fold change among 
differentially treated samples. Absolute concentrations are more difficult to 
obtain, but are more informative and can be used to derive relative 
measurements. LC-MS/MS experiments allow the plotting of signal intensities as 
a peptide elutes from the chromatographic column over time. The area under this 
curve for any given species is directly related to the abundance of the peptide 
and allows for label-free quantitation. However, the physiochemical properties of 
peptides such as hydrophobicity, charge, and size vary widely and can lead to 
differences in the mass spectrometer‟s detector response. In addition, co-elution 
of other peptides and variations in elution conditions can be problematic for 
quantitative investigations.  Protein abundance estimates using this method can 
vary by a factor of 3–5-fold from the true abundance (Ong and Mann, 2005). 
A set of chemical tagging strategies for protein quantitation utilizes the 
reactivity of the peptide N-terminus and the epsilon-amino group of lysine 
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residues. Isotope-coded protein labeling (ICPL), isotope tags for relative and 
absolute quantification (iTRAQ), and tandem mass tags (TMT) are all 
approaches that were developed to exploit the reactivity of amines to specific 
chemical groups (Ross et al., 2004; Schmidt et al., 2005; Thompson et al., 2003). 
The most recognized of these approaches, iTRAQ, incorporates isobaric tags 
that fragment in the tandem mass spectrometer to generate unique reporter ions 
at m/z values of 113–121 (Ong et al., 2004). The peak areas of the low mass-
fragment ions are integrated to determine the quantification values.  
Mass spectrometers such as quadrupoles, TOF, and Orbitrap instruments 
that have the inherent ability to detect low m/z fragment ions are typically used 
for iTRAQ experiments. Commercially available kits allow examination of up to 
eight states in one single experiment. Since the labeled peptides are isobaric, 
they should behave similarly in chromatographic separations and reveal 
quantitative differences in their fragmentation spectra. Using the iTRAQ 
approach, different samples are isolated under different conditions, trypsin 
digested, and labeled with the iTRAQ reagents. Samples are then combined and 
analyzed in a single MS/MS experiment.  As with other MS-based approaches, 
sufficient peptide separation is crucial since coeluting peptides of similar mass 
can contribute to the observed reporter ion series and interfere with the 
quantification. Ion trap mass spectrometers are typically not useful for iTRAQ 
analysis because the reporter ions generated from the fragmentation of the 
iTRAQ tags are lost with the lower 1/3 of the MS/MS data. The use of pulsed q-
dissociation (PQD) was introduced to alleviate this problem but has found limited 
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use in proteomics (Bantscheff et al., 2008; Cunningham et al., 2006; Griffin et al., 
2007). 
Using the iTRAQ approach, it is possible to compare the degree of 
phosphorylation of the proteome under different conditions. Studies performed by 
Forest White and coworkers used antiphosphotyrosine antibodies followed by 
IMAC enrichment and iTRAQ labeling to investigate the effect of epidermal 
growth factor (EGF) stimulation on the phosphorylation state of cells over time 
(Zhang et al., 2005). This study probed four time points (0, 5, 10, and 30 min) in 
a single analysis. They were able to quantify relative changes in the 
phosphorylation of 78 sites on 58 proteins (Zhang et al., 2005). This experimental 
approach highlights the utility of combining enrichment for PTMs with quantitation 
to gain additional insight into the biology of cells. It is difficult to determine what 
fraction of a peptide population is phosphorylated under certain conditions. This 
is because the unphosphorylated counterpart will behave differently in its MS 
detector response. So while it is feasible to compare unmodified forms and other 
unmodified forms or different phosphorylated forms of the same peptide under 
different conditions, it is not reliable to compare modified versus unmodified 
forms based on the ratio of reporter ion peaks generated. 
Isotope labeling and tagging strategies can be tedious, cumbersome, and 
expensive. In addition to the chromatographic peak integration method discussed 
previously, other label-free quantitation methods exist that can be applied to 
quantifying PTMs. These methods typically involve some form of spectral 
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counting and normalization for protein length (Washburn et al., 2006). It is 
debatable whether these methods are truly quantitative, and as a result, these 
methods are more commonly referred to as differential proteomic techniques. 
The spectral counting methods are based on the principle that, as the abundance 
of a protein increases in a given sample, more MS/MS spectra are isolated for 
peptides derived from that protein. Relative quantitation is inferred by comparing 
the number of spectra collected for a particular protein between experiments. 
The utility of this approach is questionable because it does not directly measure 
any physical property of the peptide and assumes a linear response for every 
protein (Bantscheff et al., 2007). As previously mentioned, the physiochemical 
properties of peptides vary widely in a sample digest and their resulting 
chromatographic and MS detector behavior can vary greatly. These methods 
provide a larger dynamic range than labeling and tagging procedures and are 
most applicable when investigating large or global protein changes among 
samples. However, the uncertain linear response among peptides and the 
potentially poor accuracy of spectral counting approaches limits their widespread 
use (Old et al., 2005). 
Summary 
Translation is a conserved, essential process in all living organisms and involves 
a myriad of biological factors.  Translation initiation is a key process to study as it 
has been implicated in the involvement of aberrant cellular states.  I focused my 
efforts on studying the eukaryotic translation initiation factor eIF3 in S. cerevisiae.  
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I hypothesize that there are unexpected and unidentified eIF3 protein-protein 
interactions and protein phosphorylations that regulate its function and activity in 
the essential process of translation initiation.  Chapter 2 of the thesis focuses on 
the identification of novel eIF3 interacting proteins.  I utilized a proteomic 
approach to elucidate previously uncharacterized protein-protein interactions 
between eIF3‟s components and other members of the yeast proteome.  Chapter 
3 deals with determining which amino acid residues among the components of 
eIF3 are phosphorylated.  I utilized radiolabeling and mass spectrometry to 
attempt to first identify phosphoproteins and then localize the phosphorylations to 
specific side chains.  Chapter 4 investigates the utility of using pulsed-Q 
disassociation to identify and quantify proteins using the iTRAQ system.  This is 
a technique that, if it would have been more successful, would have allowed me 
to apply quantitative techniques to my study of the eIF3 complex.  The final 
chapter summarizes the findings and suggests a model for what I discovered 
pertaining to the phosphorylations and interactions of eIF3.  This chapter also 
speculates as to future work and may be conducted to further the knowledge of 
the nature and function of eIF3.
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CHAPTER II 
 
eIF3 INTERACTS WITH FUN12, HCR1 AND CK2 IN S. CEREVISIAE 
 
Abstract 
The eukaryotic initiation factor 3 (eIF3) is an essential, highly conserved 
multi-protein complex that is a key component in the recruitment and assembly of 
the translation initiation machinery.  To better understand the molecular function 
of eIF3, I examined its composition and phosphorylation status in the budding 
yeast Saccharomyces cerevisiae.  I hypothesized that an optimized affinity 
purification protocol tailored for maximum recovery of the eIF3 complex will also 
yield novel identifications of proteins interacting with eIF3 core subunits.  The 
yeast eIF3 complex contains five core components: Rpg1, Nip1, Prt1, Tif34, and 
Tif35.  In work described here, liquid chromatography coupled with tandem mass 
spectrometry analysis of affinity purified eIF3 complexes showed that several 
other initiation factors (Fun12, Tif5, Sui3, Pab1, Hcr1, and Sui1) and the Casein 
Kinase 2 complex (CK2) co-purify with the core eIF3 subunits.  Reciprocal affinity 
purifications of tagged Fun12 and Sui3, two previously uncharacterized 
interactions, validated that core components of eIF3 also copurify with these two 
proteins.  These results implicate that the interaction of eIF3 with Fun12 links the 
formation of the pre-initiation complex with the binding of the 60S ribosome and 
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the termination of translation initiation.  Our finding that Pab1 interacts with the 
eIF3 complex suggests a link between eIF3 and the efficient formation of the 48S 
pre-initiation complex.  The observation that CK2 consistently copurifies with 
components of eIF3 and the important role of phosphorylation in a wide array of 
biological processes led us to examine whether it can catalyze the 
phosphorylation of components of the eIF3 complex.   
Introduction 
A key player in the assembly and function of the 48S pre-initiation 
complex is the multi-protein eIF3 complex.  While the mammalian eIF3 complex 
contains eleven subunits, much of what is known about the mechanisms of eIF3 
function have been characterized in studies of the five-subunit eIF3 complex in S. 
cerevisiae (Hinnebusch et. al., 2004).   The yeast eIF3 subunits Rpg1, Nip1, Prt1, 
Tif34, and Tif35 are homologs of the human eIF3 subunits eIF3a, eIF3c, eIF3b, 
eIF3i, and eIF3g, respectively (Table 1-1) (Browning et. al., 2001).  Yeast Hcr1 is 
homologous to human eIF3j, but does not appear to be a core eIF3 component 
(Valasek et. al., 2001).  The eIF3 complex, as well as eIF1, eIF5, and the eIF2 
ternary complex, have been identified  as part of a multifactor complex (MFC) 
that mediates the assembly of the 48S pre-initiation complex (Hinnebusch et. al., 
2004; Asano et. al., 2001) (Figure 1-4).  Within eIF3, Rpg1 and Hcr1 interact with 
Prt1 via an N-terminal RNA recognition motif (RRM) (Valasek et. al., 2001), 
which mediates protein-protein interactions despite the name.  These interactions 
are crucial for the structural integrity of the eIF3 complex and its stable 
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association with the MFC and 40S ribosome complex (Valasek et. al., 2001). 
Nip1 and Prt1 play key roles in both the assembly and maintenance of the 48S 
pre-initiation complex (Hinnebusch et. al., 2004).  Nip1 interacts directly with eIF1 
and eIF5, suggesting that it coordinates in conjunction with eIF1, Met-tRNAi, and 
eIF5 to function in both AUG start codon recognition and eIF2-GTP hydrolysis 
(Valasek et. al., 2003; Valasek et. al., 2004).  The smallest of the eIF3 subunits, 
Tif34 and Tif35, have recently been shown to promote the linear scanning of 
mRNA (Cuchalova et. al., 2010). The RNA recognition motif of eukaryotic 
translation initiation factor 3g (eIF3g) is required for resumption of scanning of 
posttermination ribosomes for reinitiation on GCN4 and together with eIF3i 
stimulates linear scanning (Cuchalova et. al., 2010). 
Materials and Methods 
Yeast strains 
TAP-tagged yeast strains used in this study have been previously 
described (Ghaemmaghami et. al., 2003). 
Purification eIF3 Components 
 The eIF3 complex was purified using a previously described protocol from 
TAP-tagged yeast strains grown to early stationary phase (O.D.600 2-4) in YPD 
medium (Powell et. al., 2004; Link et. al., 2005).  For identifying the protein 
composition of eIF3, 2 L cultures of strains expressing TAP-tagged alleles of 
RPG1, NIP1, PRT1, and TIF5 were analyzed.  BY4741, the parental strain for the 
TAP clones, was used as a negative control since it lacks any affinity tagged 
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gene.  For analysis of the association of Casein Kinase 2 (CK2) with eIF3, a 
TAP-tagged allele of CKB2 was used for a similar purification.  For validation 
experiments, TAP-tagged FUN12 and Pab1 strains were used.   
Mass spectrometry analysis of purified proteins 
Purified proteins were identified using two different methodologies.  In one 
approach, proteins were separated by 10% acrylamide SDS-PAGE. Stained 
bands were excised and in-gel trypsin digested, and purified proteins were 
identified using reversed-phase LC-MS/MS analysis (Powell et. al., 2003; Powell 
et. al., 2004).  In the second approach, components of eIF3 were identified 
directly in solution with Multidimensional Protein Identification Technology 
(MudPIT) using an LTQ linear ion trap (Thermo Electron, Inc) (Link et. al., 1999; 
Sanders et. al., 2002; Powell et. al., 2004).  Protein samples were reduced with 
1/10 volume of 50 mM DTT at 65C for 5 min, cysteines were alkylated with 1/10 
volume of 100 mM iodoacetamide at 30C for 30 min, and proteins were 
trypsinized with modified sequencing grade trypsin at 25:1 subtrate:enzyme 
ratio (Promega, Madison, WI) at 37C overnight.  A fritless, microcapillary (100 
µm-inner diameter) column was packed sequentially with the following: 9 cm of 5 
µm C18 reverse-phase packing material (Synergi 4 µ Hydro RP80a, 
Phenomenex), 3 cm of 5 µm strong cation exchange packing material 
(Partisphere SCX, Whatman) and 2 cm of C18 reverse-phase packing material. 
The trypsin-digested samples were loaded directly onto the triphasic column 
equilibrated in 0.1% formic acid, 2% acetonitrile, which was then placed in-line 
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with an LTQ linear ion trap mass spectrometer (Thermofisher, Inc.). An 
automated six-cycle multidimensional chromatographic separation was 
performed using buffer A (0.1% formic acid, 5% acetonitrile), buffer B (0.1% 
formic acid, 80% acetonitrile) and buffer C (0.1% formic acid, 5% acetonitrile, 500 
mM ammonium acetate) at a flow rate of 300 nL/min. The first cycle was a 20-
min isocratic flow of buffer B. Cycles 2-6 consisted of 3 min of buffer A, 2 min of 
15-100% buffer C, 5 min of buffer A, followed by a 60-min linear gradient to 60% 
buffer B. In cycles 2-6, the percent of buffer C was increased incrementally (from 
15, 30, 50, 70 to 100%) in each cycle. During the linear gradient, the eluting 
peptides were analyzed by one full MS scan (200-2000 m/z), followed by five 
MS/MS scans on the five most abundant ions detected in the full MS scan while 
operating under dynamic exclusion. 
Mass Spectrometry Data Analysis 
To process and analyze the mass spectrometry data, the program extractms2 
was used to generate an ASCII peak list and identify +1 or multiply charged 
precursor ions from native *.RAW mass spectrometry data files (Jimmy Eng and 
John R. Yates III, unpublished). Tandem spectra were searched with no protease 
specificity using SEQUEST-PVM  (Sadygov et. al., 2002) against the SGD 
yeast_orfs database containing 6,000 entries with a static modification of +57 on 
C (addition of a carbamidomethyl group). For multiply charged precursor ions (z 
 +2), an independent search was performed on both the +2 and +3 mass of the 
parent ion.  Data were processed and organized using the BIGCAT software 
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analysis suite (McAfee et al., 2006). A weighted scoring matrix was used to 
select the most likely charge state of multiply charged precursor ions (Link et al., 
1999; McAfee et al., 2006). From the database search, tryptic peptide sequences 
with SEQUEST cross-correlation scores (Cn)  1.5 for +1 ions,  2 for +2 ions, 
and  2 for +3 ions were considered significant and used to create a list of 
identified proteins. 
 A protein abundance factor (PAF) representing relative protein 
abundance, was calculated for each identified protein by normalizing the total 
number of non-redundant spectra that correlated significantly with each cognate 
protein to the molecular weight of the protein and multiplying by 104 (Powell et. 
al., 2004). 
Identification of Phosphorylated Components of eIF3 
TAP-Rpg1 and an unlabeled strain were metabolically labeled with 32P-
orthophosphate at early stationary phase in rich media.  eIF3 was purified, the 
protein components were separated by SDS-PAGE, and phosphorylation was 
detected by autoradiography.  Prominent bands corresponding to the molecular 
weight of eIF3 components were identified by mass spectrometry analysis of the 
corresponding bands excised from the unlabeled eIF3 complex analyzed in 
parallel. 
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Results 
In Vivo Interaction of eIF3 Components            
The goals of this study were to identify comprehensively the composition 
of the S. cerevisiae eIF3 complex and dissect the sites of in vivo phosphorylation.  
To this end, I first established an approach for high-quality purification of the eIF3 
complex using epitope tags and tandem affinity purification (TAP).  This 
approach enables the efficient recovery of proteins present at low cellular 
concentrations under native conditions (Rigaut et. al., 1999).  I used individually 
TAP-tagged yeast strains in which the fusion proteins are driven by native 
promoters, avoiding overexpression (Gavin et. al., 2002; Ghaemmaghami et. al., 
2003).  eIF3 complexes were purified in duplicate from four different yeast 
strains, each expressing a different TAP-tagged protein (Rpg1, Nip1, Prt1, or 
Tif5) (Browning et. al., 2001).  To control for purification of non-specific proteins, 
three independent extracts were prepared and analyzed in parallel from an 
isogenic untagged yeast strain (BY4741).  The isolated eIF3 complexes and 
control purifications were trypsin-digested in solution, and the proteins were 
identified using the 2-D LC-MS/MS mass spectrometry approach termed 
Multidimensional Protein Identification Technology (MudPIT) (Fig. 1B) (Link et. 
al., 1999 ;Sanders et. al., 2002; Fleischer et. al., 2006).  To estimate the relative 
abundance of each protein, a Protein Abundance Factor (PAF) was calculated 
using the acquired mass spectrometry data (Powell et. al., 2004).  A PAF is a 
label-free, semi-quantitative measure of a protein‟s relative abundance and is 
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based on the fact that a protein‟s abundance is directly related to the frequency 
at which its peptides are selected for MS/MS analysis. 
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Figure 2-1.  Purification and mass spectrometry identification of eIF3 components.  
The eIF3 complex was isolated from S. cerevisiae by tandem affinity purification (TAP).  
Complexes and control extracts were prepared in duplicate or triplicate from strains 
expressing affinity tags specific for three core eIF3 components (Rpg1, Nip1, and Prt1) 
and the translation initiation factor Tif5, as well as an isogenic, untagged yeast strain.  
(A)  Silver-stained SDS-PAGE separation of a TAP-Rpg1 purification.   (B)  MudPIT 
mass spectrometry analysis of the purifications from the four different TAP-tagged 
strains and the control strain (TAP-cntrl).  The results from one of the replicate 
experiments are shown.  The predicted molecular weights (MW) of the identified yeast 
proteins (rows) are shown in kDa.  For each tagged strain and the control, protein 
abundance factors (PAFs) were calculated for the identified proteins (PAF = (the number 
of non-redundant spectra identifying the protein) / (MW of the protein) x104 (Powell et. 
al., 2004).  The relative stoichiometry of each protein (in parentheses) was determined 
by normalizing its PAF to the PAF of the TAP-tagged protein targeted in the purification.  
(nd:not detected).  
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We routinely identified the five primary components of yeast eIF3 (Rpg1, 
Nip1, Prt1, Tif34, and Tif35) at greater than 75% coverage (Fig. 1B).  The PAFs 
suggest that these proteins have equivalent stoichiometries.  I also identified 
other translation initiation factors co-purifying in our eIF3 preparations, including 
the yeast orthologs of mammalian eIF5 (Tif5), eIF3j (Hcr1), eIF1 (Sui1), eIF2 
(Sui3), eIF5B (Fun12), and PABC1 (Pab1) (Fig 1B).  With the exception of Fun12 
and Pab1, earlier studies have reported similar eIF3 interactions (Hinnebusch et. 
al., 2004).  As expected, the PAFs values were lower for these six non-core, co-
purifying translation initiation factors. 
Interestingly, purifications based on different tagged targets yielded 
distinct subsets of co-purifying translation initiation factors, and the results were 
consistent in replicate purifications (Figure 2-1B).  I performed reciprocal 
purifications targeting the previously uncharacterized interactions of Fun12 and 
Pab1 and detected co-purifying eIF3 components but at lower abundances (Fig. 
2-1B, Table 2-1 and Table 2-2).  These results are consistent with a model in 
which these six translation initiation factors act as accessories in eIF3 function. 
Additionally, I consistently observed the yeast Casein Kinase 2 complex (CK2) 
copurifying with the TAP-Rpg1 isolation of eIF3 (Fig. 2-1B).  In yeast, CK2 is a 
tetramer consisting of two catalytic subunits (Cka1 and Cka2) and two regulatory 
subunits (Ckb1 and Ckb2) (Ackermann et. al., 2001; Pinna, 2002).  However, the 
PAF values were relatively low, indicating that the CK2 subunits associate with 
eIF3 at substoichiometric levels, consistent with the transient nature of kinase-
substrate interactions.  The CK2 subunits were not detected in the controls or in 
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a large number of independent TAP/MudPIT experiments using yeast strains with 
different TAP-tagged proteins (Link et al, manuscript in preparation), suggesting 
a specific interaction of CK2 with eIF3.   I further investigated the physical 
association of CK2 with eIF3 by targeting TAP-Ckb2 for protein purification.  LC-
MS/MS analysis of purified TAP-Ckb2 confirmed that the isolate contains all 
components of CK2 as well as all five core subunits of eIF3.  Control purifications 
from an untagged strain contained neither CK2 nor eIF3 (Table 2-3). 
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TABLE 2-1.  Mass spectrometry identification of Fun12 interactions.  Fun12 protein complexes 
were isolated from an S. cerevisiae strain expressing TAP-Fun12 and an isogenic, untagged yeast 
strain as a negative control.  MudPIT mass spectrometry analyses of the purified complexes 
were performed in triplicate. PAF values were used to approximate protein abundances as in 
Fig. 2-1.  
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Table 2-2.  Mass spectrometry identification of Pab1 interactions.  Pab1 was 
isolated from an S. cerevisiae strain expressing TAP-Pab1 and an isogenic, untagged 
yeast strain as a negative control.  MudPIT mass spectrometry analyses of the purified 
complexes were performed in triplicate.  PAF values were used to approximate protein 
abundances as in Fig. 2-1. 
 
56 
 
 
TABLE 2-3.   Mass spectrometry identification of CK2 interactions.  CK2 complexes 
were isolated from an S. cerevisiae strain expressing TAP-Ckb2 and an isogenic, 
untagged yeast strain as a negative control.  MudPIT mass spectrometry analyses of the 
purified complexes were performed in triplicate.  PAF values were used to approximate 
protein abundances as in Figure. 1. 
57 
 
Casein Kinase 2 Phosphorylates Nip1, Prt1, and Tif5 In Vitro 
 To test whether CK2 directly phosphorylates eIF3 components, I used an 
in vitro kinase assay.  I purified GST-tagged Cka1 and Ckb1 as well as eight 
randomly selected serine/threonine yeast protein kinases with GST tags as 
controls.  Isolation of the kinases was inferred from observation of SDS-PAGE 
bands with appropriate molecular sizes.  To identify autophosphorylation, control 
reactions with no eIF3 substrate were performed for each kinase.  The Cka1 
catalytic subunit phosphorylated eIF3 components above background (Fig. 2-2).  
The TAP pull-down targeting the CK2 regulatory subunit, Ckb1, phosphorylated 
eIF3 to a lesser extent.  The kinase activity of the Ckb1 preparation suggests that 
catalytic components of the CK2 complex co-purified with this regulatory subunit.  
The results of the Yck1 assays are ambiguous due to apparent Yck1 auto-
phosphorylation.  None of the other kinases had any effect, although I cannot say 
for certain they are active as no autophosphorylation was detected.  Yet it is clear 
that Cka1 has a striking ability to phosphorylate eIF3.     
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Figure 2-2.  In vitro kinase screen identifies CK2 as an eIF3 kinase.  GST-tagged 
Cka1, Ckb1, and eight control kinases were enriched and incubated with [-32P]ATP plus 
purified eIF3 treated with urea to reduce background kinase activity.  Reaction products 
were separated on a 10% SDS-polyacrylamide gel and subjected to autoradiography. In 
the far right lane, purified eIF3 without urea treatment shows significant endogenous 
kinase activity.  Arrows highlight phosphorylation of eIF3 components above background 
levels by the Cka1 catalytic subunit and to a lesser extent the Ckb1 regulatory subunit. 
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 Analysis of the eIF3-Cka1 reaction products allowed us to determine 
which eIF3 components are phosphorylated by Cka1.  SDS-PAGE showed the 
major phosphorylated product is in the size range of Nip1 and Prt1 (Fig. 2-3A).  A 
gel with a lower percentage of acrylamide allowed separation of Nip1 and Prt1 
and showed that both proteins are Cka1 substrates, with Nip1 the predominant 
target (Fig. 2-3B).  Mass spectrometry analysis of these two bands confirmed 
that only Nip1 and Prt1 were present but yielded no information as to the 
phosphorylation status of the proteins due to a failure to detect these regions of 
the proteins in the analysis.   
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Figure 2-3.  CK2 phosphorylates Nip1 and Prt1 in vitro.  SDS-PAGE separation was 
used to identify eIF3 components phosphorylated in in vitro kinase reactions with GST-
tagged Cka1.  (A)  Separation on a 10% gel indicates that CK2 phosphorylates Nip1 
and/or Prt1.  (B) Separation on a 7.5 % gel resolves the most prominent phosphorylated 
band in (A) into a doublet and shows both Nip1 and Prt1 are phosphorylated by Cka1.  
Nip1 appears to be more prominently 32P-labeled compared to Prt1. 
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Discussion 
In this study, I have used various mass spectrometry approaches to study 
the molecular composition of the highly conserved translation initiation factor 
eIF3 in S. cerevisiae.  I used tandem affinity purification to isolate eIF3 
complexes from tagged yeast strains and direct LC-MS/MS analysis of the 
complexes to identify core components of eIF3 as well as more loosely 
associated factors.  To optimize our purification strategy, I affinity purified eIF3 
based on three different tagged core components as well as the associated 
factor Tif5.  The TAP-Rpg1 and TAP-Prt1 purifications resulted in the highest 
yield of eIF3 subunits.  This finding is consistent with the previously described 
roles of Rpg1 and Prt1 in scaffolding and structural maintenance of the core eIF3 
complex and in mediating interactions with Hcr1, eIF1, eIF5, and the eIF2 ternary 
complex (Asano et. al., 2000; Asano et. al., 2001; Valasek et. al., 2001).   
We confirmed that the yeast eIF3 complex is composed of five conserved 
core components: Rpg1 (eIF3a), Nip1 (eIF3c), Prt1 (eIF3b), Tif34 (eIF3i), and 
Tif35 (eIF3g).  I also identified other translation initiation factors co-purifying with 
eIF3.  Similar to previous reports, I found Tif5 (eIF5), Sui1 (eIF1), Hcr1 (eIF3j), 
Sui3 (eIF2) associated with eIF3 at substoichiometric levels (Hinnebusch et. al., 
2004; Asano et. al., 2000; Valasek et. al., 2001).  Importantly, I also identified 
novel interactions of eIF3 with Fun12 (eIF5B) and Pab1 (PabP).  Like the other 
eIF3-associated factors, Fun12 and Pab1 were found at low levels and were 
absent from some eIF3 preparations.   Fun12 has been shown to facilitate the 
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joining of the 40S and 60S ribosomal subunits in the terminal step of translation 
initiation (Pestova et. al., 2000).  In addition, fun12 null strains have a slow 
growth phenotype and altered polysome profiles suggesting a defect in 
translation initiation (Choi et. al., 1998).   eIF3 has been shown to interact with 
the 40S subunit in the assembly of the 48S pre-initiation complex (Hinnebusch 
et. al., 2004; Asano et. al., 2001).  I postulate that the interaction of eIF3 with 
Fun12 links the formation of the pre-initiation complex with the binding of the 60S 
ribosome and the termination of translation initiation.  Similar to Fun12, pab1 
deleted strains have decreased levels of translation initiation (Sachs and Davis, 
1990).   
Pab1 has been shown to facilitate the joining of the 5‟ and 3‟ ends of 
mRNA by binding the initiation scaffold protein eIF4G (Tarun and Sachs, 1996; 
Cosson et. al., 2002).  eIF4G along with eIF4A and eIF4E form eIF4F 
(Hernandez and Vazquez-Pianzola, 2005).  eIF4F facilitates the interaction of the 
43S pre-initiation complex with the 5‟ cap structure of the mRNA producing the 
48S pre-initiation complex.  Efficient formation of the 48S pre-initiation complex is 
also dependent on eIF3 (Hinnebusch et. al., 2004).  Our finding that Pab1 
interacts with the eIF3 complex complements the previous findings and suggests 
a role in this interaction in the efficient formation of the 48S pre-initiation 
complex.  I believe that our ability to identify novel interactions of a previously 
well characterized complex stems from our approach combining gentle affinity 
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purification based on multiple eIF3 components with a sensitive and 
comprehensive protein identification using mass spectrometry. 
We found that CK2 subunits co-purify with eIF3 and that, in a reciprocal 
purification of TAP-Ckb1, eIF3 components co-purify with the CK2 complex.  Our 
data are consistent with a previously described interaction between the CK2 
kinase and eIF3 (Gavin et. al., 2002).  Using in vitro kinase assays, I found that 
CK2 phosphorylates both Nip1 and Prt1.   Interestingly, the phosphorylated 
regions of Nip1 and Prt1 are predicted to stabilize both protein interactions within 
the eIF3 complex and interactions of eIF3 with other components of the 
multifactor pre-initiation complex (Hinnebusch et. al., 2004).   
Casein Kinase 2 is a conserved serine/threonine protein kinase that is 
ubiquitous in eukaryotes.  Despite numerous studies, its regulation and 
physiological role is still poorly understood (Glover, 1998).  Yeast strains with null 
alleles of either one of the two catalytic subunits (cka1 or cka22) are viable.  
However, deletion of both genes is lethal, showing that CK2 activity is essential 
for S. cerevisiae viability (Padmanabha et. al., 1990).  Yeast strains with null 
alleles of either or both regulatory subunits (ckb1 or ckb2) are viable but are 
salt sensitive (Bidwai et. al., 1995).  A number of CK2 substrates have been 
reported, leading to the hypothesis that this kinase plays an essential role in 
several biological processes (Pinna, 2002). 
 Several other components of the yeast translation initiation machinery are 
CK2 targets.  Phosphorylation of the eIF2- subunit of the eIF2 translation 
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initiation complex is required for its optimal function but is not essential for 
viability (Feng et. al., 1994).  The yeast eIF4E cap binding protein and the 4E-BP 
protein Caf20/p20 are also phosphorylated in vitro by CK2 (Zanchin and 
McCarthy, 1995). 
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CHAPTER III 
 
DETERMINING SITES OF PHOSPHORYLATION AND THEIR RELEVANCE IN 
eIF3 
 
Abstract 
 The previous chapter demonstrated that eIF3 copurifies with the yeast 
kinase CK2.  Reciprocal isolates of affinity tagged CK2 components purify all five 
core components of eIF3.  In vivo experiments suggest that Nip1 is the 
predominant band in 32P autoradiography.  In vitro assays demonstrate that CK2 
phosphorylates both Nip1 and Prt1 of eIF3.  The next step was to use tandem 
mass spectrometry as well as immobilized metal affinity chromatography (IMAC) 
chromatography to enrich for and identify specific residues that are 
phosphorylated in vivo in S. cerevisiae.  Using this approach I was able to 
identify three sites of phosphorylation (S98, S99, and S103) on Nip1.  I also 
found that Prt1 is phosphorylated at S61 and T746.  Both the sites on Nip1 and 
Prt1 are predicted to be consensus sites targeted by CK2.  Additionally, the Tif5 
site T191 was identified as a phosphorylated residue.  However, this site is not 
predicted to be targeted by CK2.  This study targeted Nip1 with its triply 
phosphorylated motif for further investigation.  Using in vitro kinase assays, I 
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showed that a synthetic Nip1 peptide containing S98, S99, and S103 
competitively inhibits the phosphorylation of Nip1 by CK2.   
I hypothesized that the three sites of phosphorylation play a role in 
regulating the function of Nip1 and as a result, have implications in the activity of 
the eIF3 complex.  Further understanding the role that these modifications have 
on the eIF3 complex has implications into how its role is regulated at the level of 
posttranslational modifications.  To investigate this, I compared biochemical 
assays of a yeast strain with the three serines mutated to alanines with a strain 
harboring no mutations in this region.  Drug, temperature, nutrient starvation, and 
salt sensitivity were evaluated for the strains using plate assays and polysome 
profiling.  Global protein synthesis was monitored via 35S-methionine 
incorporation.  Overall, the only measureable consequence detected with 
replacement of the three Nip1 serines with alanines was a slow growth 
phenotype. 
Introduction 
 Protein kinases are key regulators of cell function and are believed to 
affect translation efficiency directly (Sonenberg et. al., 2000; Klann and Dever, 
2004).  By phosphorylating a protein, kinases can alter the substrate‟s activity, 
interactions, and stability.  The functions of several eIF complexes are regulated 
by phosphorylation.  The best characterized of these phosphorylation events 
involve regulation of eIF2 and eIF4E (Gray et. al., 1998).  eIF2 is bound to GDP 
in an inactive state at the end of each round of translation initiation. To 
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reconstitute a functional ternary complex for a new round of translation initiation, 
eIF2B catalyzes the exchange of GDP for GTP (Unbehaun et. al., 2004).  
Phosphorylation of the eIF2 subunit eIF2 effectively blocks eIF2B-mediated 
GDP-GTP exchange, thus inhibiting protein synthesis (Sudhakar et. al., 2000).  
Phosphorylation also regulates association of eIF4E with the eIF4F mRNA-cap 
binding complex. This interaction is required for cap-dependent mRNA 
translation initiation and is inhibited by the eIF4E-binding protein (4E-BP) 
(Hernandez and Vazquez-Pianzola, 2005).  Phosphorylation of 4E-BP attenuates 
this inhibition (Waskiewicz et. al., 1999).  In its hypophosphorylated state, 4E-BP 
binds to eIF4E and prevents its association with eIF4F (Gingras et. al., 1999).  In 
its hyperphosphoryated state, 4E-BP binds poorly to eIF4E.  4E-BP 
phosphorylation is stimulated by many different external stimuli including growth 
factors, hormones, and mitogens (Gingras et. al., 1999).  Finally, eIF4 is also 
phosphorylated.  Phosphorylation of S209 is stimulated by different mitogen-
activated protein kinase pathways and correlates with increased translation rates 
(Pyronnet et. al., 1999; Waskiewicz et. al., 1999; Scheper et. al., 2001). 
 Casein Kinase 2 (CK2) is a selective serine/threonine protein kinase 
composed of 4 subunits capable of phosphorylating a broad range of substrates 
including transcription factors and RNA polymerases (Ahmed and Thornalley, 
2003).  In yeast, CK2 has been implicated in cell growth and proliferation 
(Ackerman et. al., 2001).  Two subunits alpha one and alpha two contain the 
catalytic domains of the complex.  The other two beta subunits are regulatory 
domains that undergo transphosphorylation (Bidwai et. al., 1994).  The subunits 
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share > 90% homology.  Deletion of a single alpha or beta domain allows the 
cells to remain viable.  However, deletion of both of either the alpha or beta 
proteins causes lethality.  CK2 is constitutively expressed at modest levels and is 
predominantly localized to the nucleus (Poole et. al., 2005).  It is predicted to 
phosphorylate hundreds of proteins that reside in either the nucleus or cytoplasm 
(Lee et. al., 2004). 
 We have used mass spectrometry techniques to identify the components 
of eIF3 and specific residues that are phosphorylated in vivo.  Mass spectrometry 
has become the method of choice for identifying the composition of a protein 
complex (Aebersold and Mann, 2003).   However, although protein identification 
by mass spectrometry has become routine, protein phosphorylation analysis 
remains a challenging problem.  Low phosphorylation stoichiometry, 
heterogeneous phosphorylation sites, and low protein abundance contribute to 
the difficulty of phosphoprotein analysis (Farley and Link, 2009).  In addition, 
phosphopeptides are generally difficult to analyze by mass spectrometry for a 
number of reasons (Mann et. al., 2002).  Reduced ionization efficiency in positive 
ionization mode and suppression by nonphosphorylated peptides exacerbate the 
problems.  To improve the efficiency of phosphopeptide analysis, various 
strategies have been developed to enrich for phosphopeptides including strong 
cation exchange chromatography (SCX), immunoaffinity capture using 
antiphosphotyrosine antibodies, and immobilized metal affinity chromatography 
(IMAC) (Beausoleil et. al., 2004; Rush et. al., 2005; Andersson and Porath, 
1986).  IMAC was initially plagued by the nonspecific retention of peptides rich in 
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acidic amino acids, but improvements have increased both the specificity and 
sensitivity of IMAC (Ficarro, 2002; Ficarro, 2005; Moser and White, 2006).  The 
direct coupling of IMAC with high sensitivity reversed-phase liquid 
chromatography and tandem mass spectrometry has enabled us to identify 
phosphopeptides starting with small amounts of material. 
Materials and Methods 
Plasmids 
Plasmid pNip1entry (ScCD00008839) containing the wild-type Nip1 gene 
in a Gateway entry vector was obtained from the Harvard Institute of Proteomics 
(Boston, MA) and sequenced verified.  It was recombined with the destination 
clone pAG415GPD-ccdB-TAP from Addgene (Cambridge, MA) as previously 
described (Alberti et. al., 2007) to generate pNip1a. The identified sites of 
phosphorylation, S98, S99 and S101, were converted to alanines by site directed 
mutagenesis (Ishii et. al., 1998) using the primers nip1mutfwd 
(GCTCTAACTATGATGCCGCTGATGAAGAAGCCGATGAAGAAG) and 
nip1mutrev (CTTCTTCATCGGCTTCTTCATCAGCGGCATCATAGTTAGAGC) to 
generate pNip1b. The endogenous stop codon was removed from both pNip1a 
and pNip1b with the primers nip1stopfwd 
(CCATCAAATCGTCGTGCGACCCAGC) and nip1stoprev 
(GCTGGGTCGCACGACGATTTGATGG) to generate pNip1wtTAP and 
pNip1mutTAP.  All clones were sequence verified.  pNip1comp, expressing Nip1 
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with a URA3 selectable marker (Valasek et. al., 2004), was obtained from Dr. 
Alan Hinnebusch‟s laboratory. 
Direct Mapping of Phosphorylated Sites on eIF3 Components with Tandem 
Mass Spectrometry 
 The eIF3 complex was purified from whole-cell lysates prepared from 4 L 
overnight cultures of the TAP-Rpg1 strain (Powell et. al., 2004; Link et. al., 2005).  
Purified complexes were digested directly in solution with sequencing grade 
trypsin (Promega, Madison, WI) or chymotrypsin (Roche Diagnostics Corp., 
Indianapolis, IN) (Sanders et. al., 2002) and analyzed by MudPIT using an LTQ 
linear ion trap mass spectrometer (Thermo Electron, Inc). 
Mapping eIF3 Phosphopeptides using IMAC Enrichment and Tandem Mass 
Spectrometry.  
The S. cerevisiae strain expressing a TAP-Rpg1 was grown overnight 
(O.D.600 2-4) in 16 L of YPD medium.  eIF3 complexes were TAP-isolated from 
whole cell lysates (Link et. al., 2005).  The pH of the eluted eIF3 mixture was 
adjusted to 8.0 using 1 M Tris pH 8.0.  Cysteine residues were reduced with DTT 
and alkylated with iodoacetamide.  The proteins were digested with 20 µg of 
sequencing grade trypsin (Sanders et. al., 2002) (Promega, Madison, WI).  The 
tryptic peptide mixture was divided into 1 mL aliquots and lyophilized.  To methyl 
esterify the peptides, a pre-mix of 1 mL anhydrous methanol and 50 L thionyl 
chloride (Sigma-Aldrich, St. Louis, MO) was added to the dried peptides.  The 
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mixture was sonicated for 15 min at room temperature and incubated at room 
temperature for 2 h.  Esterified peptides were lyophilized to dryness. 
An IMAC column was constructed using a fritted 20 cm long piece of 200 x 
360 m fused silica capillary (FSC).  The column was packed with POROS MC 
20 beads (Applied Biosystems, Foster City, CA) to a length of 15 cm.  The 
column was rinsed with 100 mM EDTA (Sigma-Aldrich, St. Louis, MO), pH 8.5 
and then with deionized water.  The column was charged with 100 mM Iron(III) 
chloride solution (Sigma-Aldrich, St. Louis, MO).  Finally, the IMAC column was 
rinsed with 0.1% acetic acid. 
The dried, esterified peptides were resuspended in 180 μL of 33% 
methanol, 33% acetonitrile, and 0.034% acetic acid and loaded onto the IMAC 
column.  Following loading, the column was rinsed with a solution of 25% 
acetonitrile, 100 mM NaCl, and 1% acetic acid. 
A reversed-phase capture column was constructed from 20 cm of 100 x 
360 m FSC fritted at one end using an inline MicroFilter Assembly (Upchurch 
Scientific, Inc, Oak Harbor, WA).  The RP-capture column was packed with 
POROS 10 R2 (Applied Biosystems, Foster City, CA) to a length of 10 cm.   
Using a 0.012 X 0.060 inch piece of Teflon tubing (Zeus, Orangeburg, SC), the 
RP-capture column was butt-jointed to the IMAC column.  Phosphopeptides were 
eluted from the IMAC column onto the RP-capture column with 250 mM sodium 
phosphate, pH 8.0 solution. 
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The RP-capture column was rinsed overnight with 5% acetonitrile and 
0.1% formic acid and attached to an analytical RP chromatography column (100 
x 365 m FSC with an integrated laser-pulled emitter tip packed with 10 cm of 
Synergi 4 m RP80A (Phenomenex) via the inline MicroFilter Assembly for LC-
ESI-MS/MS analysis.  Peptides were eluted using the following linear gradient: 0 
min: 0% B, 120 min: 40% B, 140 min: 60% B, 160 min: 100% B at a flow rate of 
400 nL/min (mobile phase A: 5% acetonitrile, 0.1% formic acid and mobile phase 
B: 80% acetonitrile, 0.1% formic acid).   
Spectra were acquired with a LTQ linear ion trap mass spectrometer 
(Thermo Electron, Inc).  During LC-MS/MS analysis, the mass spectrometer 
performed automated data-dependent acquisition with a full MS scan followed by 
three MS/MS scans on the most intense ions while operating under dynamic 
exclusion.   
Mass Spectrometry Data Analysis 
 Data analysis of spectra generated by the mass spectrometer was 
performed as described in Chapter 2.  To validate candidate phosphopeptides, 
tandem mass spectra were manually evaluated to identify evidence of neutral 
loss of phosphoric acid caused by fragmentation of the precursor ion (98 (z=+1), 
49 (z=+2), or 32.7 (z=+3) m/z units relative to the precursor). For all IMAC mass 
spectrometry data, the acquired mass spectrometry data were searched against 
the yeast ORF database using the Sequest algorithm assuming static 
modifications of +14 on D, E, and the C-termini, static modification of +57 on C, 
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and variable modifications of +80 on S, T, and Y (Yates et. al., 1995).  Our 
criteria in identifying phosphorylations were: 1) a series of at least 3 y or b ions 
with an appropriate +80 Dalton shift, and 2) ions indicating a neutral loss of 
phosphoric acid from the precursor ion. 
Scansite Predictions 
 The Scansite computational tool is accessible via the web-page 
(http://scansite.mit.edu).  The accession number for each individual protein of 
interest is entered into the appropriate field and the yeast database selected.  
The casein kinase 2 motif is selected (SXXE/D) along with the stringency level 
(high) and the scan is submitted.  Scansite generates scores based upon how 
well the submitted sequence matches the predicted motif.  A high stringency 
level reflects a Scansite score that falls within the top 0.2% of scores when the 
motif matrix is applied to a reference dataset from SWISS-PROT.  Medium and 
low stringencies reflect Scansite scores of 1% and 5% respectively.  The search 
is then subsequently repeated at the medium and low stringency levels. 
Inhibition of In Vitro Phosphorylation  
A peptide inhibitor containing Nip1 phosphorylation sites (H2N-
SSNYDSSDEEDSDDDGK-OH) was synthesized to mimic the tryptic peptide of 
Nip1 identified by mass spectrometry (New England Peptides Gardner, MA).  A 
control peptide (H2N-ISQAVAHAHAEINEAGR-OH) that contains an identical 
number of amino acids but lacks CK2 consensus sequence sites for 
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phosphorylation was synthesized (New England Peptides).  The peptides were 
suspended at 1 mg/mL in 100 mM Tris, pH 8.0 to a concentration of 1 mg/mL.  
The CK2 inhibitor (E)-3-(2,3,4,5-Tetrabromophenyl)acrylic acid (TBCA) and the 
CK1 inhibitor 3-[(2,4,6-Trimethoxyphenyl)methylidenyl]-indolin-2-one (IC261) 
were obtained from Calbiochem (Gibbstown, NJ) and resuspended to 1 mg/mL in 
DMSO (Pagano et. al., 2007; Knippschild et. al., 1997).  The peptides and kinase 
inhibitors were added to kinase reactions described above to a final 
concentration of 33 g/mL.  
Polysome Profile Analysis 
 Overnight cultures of the appropriate yeast strains were grown overnight 
from single colony inoculations of 50 mL of YPD culture to an OD600=0.5-1.  
Cyclohexamide is added to a concentration of 50 g/mL and the resulting mixture 
chilled on ice. Cells were centrifuged for 10 min at 3000 g and washed once with 
breaking buffer (10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 30 mM MgCl2, 50 g/mL 
cyclohexamide, 200 g/mL heparin).  Cells were lysed in 200 L of breaking 
buffer in a bead beater with 0.5 mm glass beads for three cycles of one min 
beating followed by one min on ice.  Lysates were centrifuged for 2 min at 13,000 
g and the cleared supernatant loaded onto a 12 mL 7-47% sucrose gradient.  
Gradient solutions were prepared in gradient buffer (50 mM Tris-acetate, pH 7.0, 
50 mM NH4Cl, 12 mM MgCl2).  Lysates were separated within the gradients by 
spinning for 18 hr at 20,000 rpm in a Sorvall SW-41 rotor.  Polysome profiles 
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were collected and monitored at an absorbance of 254 nm using an Agilent 1100 
series microfraction collector and flow cell.  
Halo Growth Assay 
 Plates for this assay were prepared with YPD plus 1% agar.  50 L of an 
overnight culture of BY4741 yeast was added to the surface of the plate and 
spread evenly with a flame sterilized applicator.  Four sterile discs were added 
evenly spaced onto the surface of the plate containing the yeast culture.  Casein 
kinase 2 inhibitors, casein kinase II inhibitor 1 (TBB), casein kinase I inhibitor 
(D4476), casein kinase II inhibitor III (TBCA), casein kinase II inhibitor (DMAT), 
3-[(2,4,6-Trimethoxyphenyl)methylidenyl]-indolin-2-one (IC261), 5,6-Dichloro-1-b-
D-ribofuranosylbenzimidazole (DRB) (all EMD Chemicals), were added to a 
concentration up to 10X their inhibitory constant.  The kinase inhibitors were 
either obtained in solution (10 mM DMSO) or dissolved to 10 mM in DMSO and 
tested by spotting onto sterile discs on a lawn of BY4741 yeast cells.  As a 
negative control, DMSO was spotted onto each lawn.  Inhibition of growth should 
be evident as a halo of nongrowth around the sterile paper disc spotted with the 
kinase inhibitor. 
35S-Met Incorporation 
 Overnight cultures grown in YPD were diluted 1:10 into 1 mL of SC-Met to 
an OD600 of approximately 0.5 in triplicate in a 96-well 2 mL culture plate and 
grown for 3 hr at 30C.  Cells were counted and normalized to each other.  Each 
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sample in triplicate was labeled with 10 Ci/mL 35S-methionine for 15 min at 
30C.  Labeling was stopped by the addition of 1/10 volume of 100% TCA to 
each culture and heating the entire 96-well plate at 100C for 30 min.  TCA 
precipitates were collected on Whatman GPC filters, washed sequentially with 2 
mL of each 10% TCA and 95% ethanol.  The filter papers were then scintillation 
counted in 5 mL of Universol (ICN).  Experiments were performed in triplicate to 
measure the standard deviation. 
Quantifying the Doubling time of Wild-type and Mutant of Nip1  
The growth rate of nip1 deletion mutants carrying either pNip1a (NIP1+), 
pNip1b (nip1-S98,99,101A) or pNIP1b plus pNip1comp (NIP1+) was measured.  
Single colonies from each strain were inoculated into YPD and grown overnight 
at 30C.  Cell density was calculated using a Countess automated cell counter 
from Invitrogen (Carlsbad, CA).  10,000 cells of each strain were transferred to 
fresh 6 mL cultures of YPD at 30C.  Aliquots from each strain were collected 
periodically, and cell density was calculated in triplicate until the cultures reached 
stationary phase.  The triplicate density measurements were averaged.  The 
doubling time (tdub) for each strain was determined from the logarithmic growth 
phase of the cells using the following formula: 
tdub = ln 2/((ln D2/D1)/tmin) 
Where D is the cell density and tmin is the change in time in min from D1 to D2.  
The experiment was repeated in triplicate and the resulting doubling times were 
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averaged for each strain.  A Student‟s t-test (95% confidence interval) was 
performed on the data to determine its statistical significance. 
Results 
Mass spectrometry Identification of In Vivo Prt1 and Tif5 Phosphorylation 
Sites 
Mass spectrometry techniques can be used to pinpoint exact sites of 
protein modification, including phosphorylation.  Our initial approach used 
MudPIT to identify eIF3 phosphopeptides directly from complexes purified from 
the TAP-Rpg1 strain.  This direct approach avoided sample loss associated with 
strategies to enrich for phosphopeptides.  TAP-isolated eIF3 samples were 
digested separately with either trypsin or chymotrypsin and analyzed using 
MudPIT.  I used two different proteolytic enzymes to maximize peptide coverage 
and to facilitate identification of candidate phosphorylation sites on multiple 
overlapping peptides (MacCoss et. al., 2002).   
Phosphorylations present several hallmarks in mass spectrometry 
analysis.  First, the mass of a phosphorylated residue is increased by 80 Da.  
Second,  when peptides containing phosphorylated serine or threonine residues 
are fragmented by resonance excitation in an ion trap, they commonly undergo a 
gas-phase ß-elimination reaction, resulting in the neutral loss of phosphoric acid 
(-H3PO4 or 98 Da) (Mann et. al., 2002).  Depending on the charge of the 
precursor ion, neutral loss of phosphoric acid appears as a decrease of 98 
(z=+1), 49 (z=+2), or 32.7 (z=+3) m/z units from the precursor.  Finally, because 
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a phosphorylated residue increases the net negativity of the peptide in solution, it 
is expected to have a shorter retention time during SCX chromatography 
compared to the unmodified peptide (Beausoleil et. al., 2004).  Our criteria in 
identifying phosphorylations were: 1) a series of at least 3 y or b ions with an 
appropriate +80 Dalton shift for the addition of a phosphate group, and 2) ions 
indicating a neutral loss of 98 Da from the precursor ion. 
To identify candidate phosphorylation sites I used the Sequest algorithm 
to search for additions of 80 Da at serine, threonine, and tyrosine residues (Yates 
et. al., 1995).  I anticipated that the in vivo phosphorylation would be incomplete 
(< 50%), and therefore I expected to identify the corresponding unmodified 
peptide as well.  Once candidate sites were identified, I manually inspected the 
data for evidence of neutral loss events indicating phosphorylation.  In this way, I 
identified two phosphorylation sites in Prt1 (Figure 3-1 and 3-2).  Phosphorylation 
of a high stringency CK2 consensus site at S61 (PVDDIDFpSDLEEQYK) was 
identified in two independent trypsin and chymotrypsin experiments 
(http://scansite.mit.edu).  Phosphorylation of a low stringency CK2 consensus 
site at T746 (CK2 consensus sequence: DASSDDFTpTIEEIVEE) was identified 
following trypsin digestion, but not using chymotrypsin (Figure 3-3).  The 
corresponding unmodified versions of these peptides were also identified.  As 
predicted, analysis of the SCX fractions in the MudPIT runs showed the 
phosphorylated peptides eluted first followed by the unmodified peptides.  
Additionally, a single Tif5 phosphopeptide was detected that contained a 
phosphorylated T191 (SQNAPSDGTGSSpTPQHHDEDEDELSR) (Figure 3-4).  
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However, the site does not fit the CK2 consensus sequence.  To our surprise, I 
did not detect phosphopeptides from Nip1. 
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 Figure 3-1.  MS/MS spectra from eIF3 showing in vivo phosphorylation of Prt1 at 
S61.   An MS/MS spectrum generated from trypsin-digested eIF3 showing in vivo 
phosphorylation of a Prt1 peptide at S61.  The spectrum significantly matched the 
trypsin-generated peptide of Prt1 (Sequest Xcorr = 5.5).  The spectrum shows the 
addition of 80 Da in the m/z values for the y8-15 and b15-16 ions.  The m/z value of the most 
prominent ion corresponds to the neutral loss of phosphoric acid (+2) from the precursor 
ion of 1184.18 (+2).   
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Figure 3-2.  MS/MS spectra from eIF3 showing in vivo phosphorylation of Prt1 at 
S61.  An MS/MS spectrum generated from chymotrypsin-digested eIF3 showing 
in vivo phosphorylation of a Prt1 peptide at S61.  The spectrum significantly 
matched the chymotrypsin-generated peptide of Prt1 (Sequest Xcorr = 4.0).  The 
spectrum shows the addition of 80 Da in the m/z values for the y7-16 ions.  The 
m/z value of the most prominent ion corresponds to the neutral loss of 
phosphoric acid (+2) from the precursor ion of 1362.8 (+2). 
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Figure 3-3.  MS/MS spectra from eIF3 showing in vivo phosphorylation of Prt1 at 
T746.  An MS/MS spectrum generated from trypsin-digested eIF3 showing in vivo 
phosphorylation of a Prt1 peptide at T746.  The spectrum significantly matched 
the trypsin-generated peptide of Prt1 (Sequest Xcorr = 3.5).  The spectrum 
shows the addition of 80 Da in the m/z values for the y14-16 and b16 ions.  The m/z 
value of the most prominent ion corresponds to the neutral loss of phosphoric 
acid (+2) from the precursor ion of 1661.1 (+2). 
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Figure 3-4.  MS/MS spectra from eIF3 showing in vivo phosphorylation of Tif5 at 
T191.  An MS/MS spectrum generated from trypsin-digested eIF3 showing in vivo 
phosphorylation of a Tif5 peptide at T191.  The spectrum significantly matched the 
trypsin-generated peptide of Tif5 (Sequest Xcorr = 4.2).  The spectrum shows the 
addition of 80 Da in the m/z values for the y19-24 and b15-16 ions.  The m/z value of the 
peak at 927.2 corresponds to the neutral loss of phosphoric acid (+3) from the precursor 
ion of 959.8 (+3). 
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Our results using metabolic labeling (Figure 2-3) and the mass 
spectrometry illustrate the need for a multifaceted approach to comprehensively 
identify phosphorylations.  32P-metabolic labeling revealed that Nip1 is 
phosphorylated.  Mass spectrometry analysis of eIF3 complexes identified 
specific sites of phosphorylation in Prt1 and Tif5, but not Nip1. 
Mass spectrometry Identification of In Vivo Phosphorylation of Nip1 at S98, 
S99, and S103 using IMAC phosphopeptide enrichment 
In considering our failure to identify Nip1 phosphopeptides in our direct 
mass spectrometry analysis, I speculated that either Nip1 phosphopeptides were 
not retained in either the 2-D LC‟s SCX or RP chromatography steps or that the 
phosphopeptide ion signals were being repressed by co-eluting 
nonphosphorylated peptides.  Therefore, I enriched for phosphorylated peptides 
from digested eIF3 complexes using an optimized immobilized metal affinity 
chromatography (IMAC) protocol (Moser and White, 2006).  Purified eIF3 
complexes were digested with trypsin, and the peptides were converted to methyl 
esters.  Phosphorylated peptides were enriched by Fe(III)-charged IMAC prior to 
LC-MS/MS analysis.  Using this approach and the criteria described earlier for 
validating the MS/MS spectra, I identified multiple Nip1 peptides that were 
phosphorylated at S98, S99, and S103 (Fig. 3-5).  All three sites are predicted to 
be high stringency substrates for CK2 (CK2 consensus sequence: 
LKSSNYDpSpSDEEpSDEEDGKK) (Obenauer et. al., 2003).  The stringency is 
defined by the Scansite algorithm and reflects a motif match of the target protein 
with the casein kinase 2 motif of SXXD/E that falls within the top 0.2% of scores 
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when the motif matrix is applied to a reference dataset from SWISS-PROT using 
Scansite.  S99 was phosphorylated in all the Nip1 phosphopeptides that I 
identified, suggesting constitutive phosphorylation, while the phosphorylation of 
S98 and S103 was variable (Table 3-1).  The corresponding unmodified peptides 
were not identified in our LC-MS/MS analysis of unenriched samples.  Thus the 
IMAC enrichment enabled us to analyze these particular peptides.  However, the 
IMAC approach did not allow us to detect the singly modified peptides previously 
identified in this study for Prt1 and Tif5.  This is a commonly cited limitation of the 
IMAC protocol in that it preferentially binds multiply phosphorylated peptides 
(Bodenmiller et. al., 2007). 
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Figure 3-5. Nip1 is phosphorylated at S98, S99, and S103.  An MS/MS spectrum 
generated after IMAC-enrichment of phosphopeptides from trypsin-digested eIF3 
showing in vivo phosphorylation of a Nip1 peptide at S98, S99, and S103.  The spectrum 
significantly matched the trypsin-generated peptide of Nip1 (Sequest Xcorr = 3.1).  The 
spectrum shows the addition of 80 Da at S98, S99, and S103.  The m/z values of the 
most prominent ions in the MS/MS spectrum correspond to the neutral loss of one and 
two phosphoric acids from the precursor ion of 1131.6 (+2). 
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TABLE 3-1. Summary of Nip1 peptides identified by LC-MS/MS after IMAC-
enrichment of phosphopeptides from trypsin-digested endogenous eIF3.  The 
table shows the precursor ion and the m/z of the most intense fragment ion (base peak) 
in the corresponding MS/MS spectrum.  The observed neutral loss, predicted charge 
state of the precursor ion (Z), and the Sequest cross-correlation value (Cn) to the 
phosphopeptide sequences are shown.  The peptide sequences show the predicted 
upstream and downstream amino acids flanking the peptides. 
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Phosphorylation of Nip1 by CK2 
To test whether CK2 targets Nip1 specifically at S98, S99, and S103, the 
sites identified by mass spectrometry, a synthetic peptide with a sequence 
identical to the tryptic fragment (H2N-SSNYDSSDEEDSDDDGK-OH) was 
generated and added to the in vitro kinase assays.  Addition of the competitor 
peptide reduced phosphorylation of Nip1 (Fig. 3-6, compare lanes 1 and 2), 
indicating that these specific sites identified on Nip1 are phosphorylated by CK2 
in vitro.  The residual phosphorylation of Nip1 in the lane with the peptide mimic 
may result from either incomplete competition or CK2 phosphorylation of Nip1 at 
other site(s).  The addition of a control peptide of unrelated sequence and 
identical length (H2N-ISQAVAHAHAEINEAGR-OH) had no effect on Nip1 
phosphorylation (Fig 3-6, lane 3).   
 
89 
 
 
Figure 3-6.  Synthetic Nip1 peptide inhibits the in vitro phosphorylation of Nip1.  A 
peptide was synthesized that mimics the unmodified tryptic peptide of Nip1 identified as 
phosphorylated by mass spectrometry.    Separation on a 4-12% gradient gel for an 
extended time allows for better resolution of the Nip1-Prt1 region of the gel.  The ability 
of this peptide mimic to inhibit in vitro phosphorylation is shown (lane 2).  A control 
peptide added to the kinase assay indicates that this inhibition is specific to the Nip1 
peptide (lane 3).  Addition of a CK2 inhibitor, TBCA, abolishes the in vitro 
phosphorylation of Nip1 (lane 5).  An unrelated kinase inhibitor, IC261, does not affect 
the in vitro phosphorylation of Nip1 (lane 4). 
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Phosphorylation of Nip1 at Additional Sites 
The incomplete inhibition of in vitro Nip1 phosphorylation by the peptide 
containing S98, S99, and S103 suggested that there may be additional 
phosphorylation sites on Nip1.  To address this possibility, I examined in vivo 
phosphorylation of a mutant version of Nip1 lacking these three CK2 sites. Using 
a TAP-tagged Nip1 plasmid, I replaced S98, S99, and S103 with alanines.  
Strains with the wild-type and nip1S98,99,101A mutant plasmids in a nip1 null 
background were metabolically labeled with 32P-orthophosphate.  Following TAP 
purification of Nip1, autoradiography showed a reduction in the level of 
phosphorylation of nip1S98,99,101A mutant protein (Fig. 3-7).  The signal for the 
mutant strain represents a 41% reduction compared to the wild-type as 
determined by densitometry (Fig. 3-6), consistent with the phosphorylation of 
other Nip1 sites. 
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Figure 3-7.  Mutation of S98, S99 and S103 in Nip1 reduces in vivo 
phosphorylation.  nip1 null mutants containing plasmids expressing either wild-type 
Nip1 or a Nip1 mutant protein in which S98, S99 and S103 were replaced by alanines 
were examined.  SDS-PAGE separation of TAP-Nip1 following in vivo 32P metabolic 
labeling.  The  S98,S99, S103A mutation results in a 41% reduction of the mutant signal 
relative to wild-type based on densitometry using values normalized for the -TAP 
loading control and measured in triplicate.  The error bar represents deviation among the 
densitometry measurements in triplicate of the mutant sample normalized relative to the 
wild-type control.  Error bars are absent in the wild-type since the value is normalized to 
itself.  As a control, western blotting with an -TAP antibody shows equivalent amounts 
of TAP-Nip1 in each lane. 
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The Biological Significance of the Nip1 Phosphorylation at S98, S99, and 
S103 
 To test the functional importance of the S98, S99, and S103 
phosphorylation sites, I closely examined a nip1S98,99,101A mutant strain.  I 
compared yeast strains with either wild-type Nip1 or nip1S98,99,101A expressed 
from low-copy-number plasmids in a nip1 null background.  The most striking 
difference observed between the mutant and wild-type strains was a marked 
increase in doubling time for the nip1S98,99,101A mutant (Fig. 3-8).  The wild-
type strain doubled every 111 ± 12 min, within the normal range for S. cerevisiae.  
However, the nip1S98,99,101A mutant strain doubled every 148 min ± 10 min, a 
33% increase (p-value = 0.00687).  Complementing the mutant strain with a wild-
type Nip1 plasmid results in a restoration of the doubling time to normal levels 
(112 min ±8 min). 
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Figure 3-8.  Mutation of S98, S99 and S103 in Nip1 increases the doubling time of 
yeast.  Doubling time for each strain (wild-type Nip1 and a nip1S98,99,101A mutant) 
was determined from the logarithmic growth phase of the cells in triplicate (n=3).  
Comparison of doubling times reveals that the strains harboring the mutation have a 
doubling time increased by 33%.  A one-tailed t-test reveals a p-value between the wild-
type and mutant doubling times of 0.00687.  This defect is rescued with a wild-type copy 
of Nip1 in the mutant strain.  The error bars represent the standard deviation of the 
measurements of doubling times performed in triplicate. 
 
94 
 
To further investigate the biological significance of the identified 
phosphorylation events, I investigated the polysome profiles of the mutant and 
wild-type strains.  Polysome profile defects can indicate problems in a multitude 
of cellular process including ribosome biogenesis, translation initiation, and 
translational processes.  Mutant and wild-type strains were tested under a variety 
of conditions including temperature selection, salt stress, and drug exposure.  
Figure 3-9 shows a representative set of polysome profiles comparing wild-type 
and mutant strains of nip1.  The representative profiles reflect what was 
consistently observed for the conditions tested.  There were no discernable 
differences between the two strains.  If a defect were present for the mutant 
strain, the peak intensities shown in the profiles would be different between the 
strains.  For example, an increase in the populations of the 40S and 60S peaks 
with a simultaneous decrease in the 80S peak intensity would be indicative in an 
observed defect in translation initiation.  However, this was not the case. 
The rate at which the mutants globally synthesize proteins was measured 
via 35S-methionine experiments.  Decreased 35S incorporation reflects a global 
decrease in protein synthesis.  However, this set of experiments showed no 
difference between the incorporation rates of 35S between the wild-type and 
mutant strains, thereby indicating no measurable defect in overall rates of protein 
synthesis (Figure 3-10).  Given that the growth rate quantification experiment 
yielded a measurable difference between the doubling times of the mutant and 
wild-type strains, I further investigated the growth rate of the strains under 
stressed conditions.  These stressed conditions included high salt, drugs that 
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selectively inhibit steps in translation (hygromycin, rapamycin, paromycin), 
nutrient starvation (-uracil, -leucine), and temperature shock (25C and 37C).  
Under the conditions tested, no additional defect in the growth rates of the strains 
was observed (Figure 3-11).  As an addition, growth in the presence of the drug 
sulfometuron methyl (SM) was tested.  SM induces amino acid starvation by 
selectively inhibiting translation initiation.  If the mutant nip1 has defects in 
translation initiation, I postulated that strains exposed to the drug and harboring 
the mutation, would be hypersensitive to its presence and show diminished 
growth rates compared to wild-type strains.  Unfortunately, these experiments 
showed no discernable growth rate differences between the strains  Figure 3-12).  
This experiment was repeated at 25 C, 30C, and 37C with similar results.  
gcn2 strains were chosen as a positive control since they have a known 
hypersensitivity to SM. 
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Figure 3-9.                           -                             C.  A) Wild-type 
yeast polysome profile with the corresponding peaks labeled as to the proteins the 
predominantly compose them.  B) A nip1S98,99,101A mutant yeast lacking the 
identified phosphorylation sites on Nip1 were analyzed in this polysome profile.  
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Figure 3-10.  35S-methionine incorporation.  The global rates of protein synthesis 
were compared for the mutant and wild-type Nip1 strains.  A control strain of BY4741 
yeast cells containing Nip1 on its chromosomal locus was used as a control.  No 
difference was observed for the rates of 35S-met incorporation between the strains 
containing either wild-type or a nip1S98,99,101A mutant allele on a plasmid. 
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Figure 3-11.  Plate growth assay comparison between a nip1S98,99,101A mutant 
and wild-type Nip1 strains.  Strains harboring the alanines mutations were compared 
with strains containing wild-type copies of Nip1 for their ability to grow on a variety of 
media.  None of the conditions produced a difference between the two strains.  The 
YBR159W strain was chosen as a positive control. 
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Figure 3-12.  SM growth assay.  The drug sulfometuron methyl was used to evaluate 
defects in translation initiation for the mutant nip1S98,99,101A  strain.  However, the 
mutant nip1 strains showed no hypersensitivity to the drug as is seen with the positive 
control gcn2 null strain. 
100 
 
Discussion 
To identify specific sites of phosphorylation, I analyzed TAP-isolated eIF3 
complexes directly by LC/MS/MS.  In this way, I identified two phosphorylation 
sites in Prt1 (S61 and T746) and one in Tif5 (T191).  To our surprise, I were 
unable to identify any phosphorylation sites in Nip1 using this method. I enriched 
for eIF3 phosphopeptides using IMAC and then analyzed the peptides using 
LC/MS/MS.  This approach enabled us to identify three phosphorylation sites in 
Nip1 (S98, S99, and S103).  Using the Scansite algorithm 
(http://scansite.mit.edu), Nip1 is predicted to contain 5 sites that are high 
stringency CK2 targets.  Of these five, S98, S99, and S103 were identified in this 
study.  There was no evidence found to support the remaining two sites S56 and 
S62.  However, our mass spectrometry data showed evidence of additional 
phosphorylations.  In a number of tandem spectra, the most intense fragment ion 
was due to a neutral loss of 98, 49, or 32.6 Da, indicating phosphorylation.  
However, insufficient fragmentation prevented us from confidently identifying the 
sequences.  Additionally, Rpg1 is the only other member of the eIF3 complex 
predicted to contain a high stringency CK2 site at T513.  No evidence was found 
to support this and the lack of a signal in the Rpg1 region of the autoradiography 
(Fig. 2, lane C) supports the conclusion that this particular potential CK2 site is 
not targeted for phosphorylation. 
To comprehensively identify the eIF3 phosphorylation sites, complete 
sequence coverage of proteins by mass spectrometry will be required.  However, 
current mass spectrometry protocols seldom achieve complete coverage.  A 
101 
 
fraction of the proteolytic peptide fragments are either too small or too large to be 
confidently analyzed by mass spectrometry.  In addition, the physiochemical 
properties of phosphopeptides compound the problems of obtaining 
comprehensive coverage.  Because of the negative charge on phosphate 
groups, the ionization efficiency of phosphopeptides in positive ion mode is 
reduced.  Furthermore, because a phosphopeptide is typically at a lower 
abundance relative to the equivalent nonphosphorylated peptide, the more 
prevalent mass spectrometry signal of nonphosphorylated peptide can suppress 
the signal of the phosphopeptides (Chang, 2006; Bodnar et. al., 2003; Zhen et. 
al., 2004; Mirgorodskaya et. al., 2005).   
We have found that casein kinase 2 (CK2) plays an important role in 
phosphorylating eIF3 components.  Most of the phosphorylation sites I have 
identified fit the CK2 consensus sequence with high stringency: S98, S99, and 
S103 on Nip1 and S61 on Prt1.  T746 on Prt1 fits the consensus with low 
stringency, while T191 on Tif5 does not match. 
To further our understanding of how phosphorylation might regulate 
translation initiation, I used mutational analysis to investigate the functional 
importance of the phosphorylated CK2 consensus sites in Nip1.  Mutation of S98, 
S99 and S103 causes a 33% increase in the doubling times for the mutant strain.  
This observation suggests that the phosphorylation events occurring in the region 
of these sites S98, S99 and S103 are necessary for normal cell growth or 
division.  In the absence of these three sites, in vivo phosphorylation of Nip1 was 
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reduced by only 41%.  This observation is consistent with our mass spectrometry 
analysis in which I was tantalized by several spectra that showed hallmarks of 
phosphorylation but did not contain enough fragment ions to provide sequence 
information. Therefore, I believe there are additional phosphorylation sites in the 
eIF3 complex yet to be identified.  It is interesting that while the mutant strains 
show an increase in their doubling times, their 35S incorporation and polysome 
profiles appear normal.  A defect could still exist in translation initiation, but it is 
possible that the available techniques are not sensitive enough to detect it.  
Translation is also a complicated process and involved in many aspects of cell 
functioning.  It could be that the phosphorylations of Nip1 are a triggering event in 
cell cycle progression but not necessary for efficient translation initiation.  
Additional genetic and biochemical experiments will be required to dissect the 
functional and mechanistic consequences of these phosphorylation events.  
Collectively, our results provide a comprehensive characterization of the 
phosphorylation of eIF3 and its targeting by CK2.  Experiments designed to more 
precisely determine the consequence of the phosphorylation evens observed for 
Nip1 yielded little proof as to its role.  However, this region is proposed to be 
involved with stabilizing interactions between Nip1 and Prt1 to form the active 
eIF3 complex.  It could be speculated that losing the phosphorylation events will 
greatly increase the hydrophobicity in the region of Nip1.  A loss of strong polar 
interactions between Prt1 and Nip1 could reduce the stability of the eIF3 
complex.  The net result would be a smaller pool of eIF3 available to perform its 
native biological functions.  This could account for the marked increase in the 
103 
 
doubling times observed for strains lacking the three serine sites on Nip1.  
Chapter five will further discuss how future experiments could address this 
concept.  Overall, this work can serve as a blueprint for the discovery of kinases 
that phosphorylate components of other protein complexes in vivo.  In addition, 
this approach can be employed in the discovery of enzymes responsible for other 
types of post-translational modification including ubiquitination, acetylation, and 
methylation. 
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CHAPTER IV 
 
THE UTILITY OF USING iTRAQ WITH PQD 
 
Abstract 
The use of iTRAQ reagents to quantify either the relative or absolute 
amounts of proteins in biological samples has become a widespread technique in 
quantitative proteomics.  The method provides a robust method to 
simultaneously identify proteins in complex mixture while yielding precise 
quantification data.  However, ion trap mass spectrometers are typically not 
useful for iTRAQ analysis because the reporter ions generated from the 
fragmentation of the iTRAQ tags are lost along with the lower 1/3 of the MS/MS 
data.  This is a result of using the ion trap to trigger collision induced dissociation 
(CID).  Other types of mass analyzers including time of flight (TOF) instruments 
such as a quadrupole-TOF (Q-TOF) and TOF-TOFs contain a dedicated collision 
cell to perform CID.  The Orbitrap mass analyzer, in combination with the higher 
energy collision dissociation cell (HCD), is also able to retain the lower mass 
ions.  To expand the use of iTRAQ reagents to ion trap mass spectrometers, the 
ion trap‟s manufacturer introduced the use of pulsed-q dissociation (PQD) for 
retention of the lower 1/3 of the MS/MS data.  Using the 4-plex iTRAQ system, I 
evaluated the utility of using PQD to generate both peptide sequencing 
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information and iTRAQ reporter ions for quantitation.  When compared with CID, 
PQD produces more reliable detection of iTRAQ reporter ions.  However, when 
using PQD, fewer peptides are identified in biological samples due to the less 
efficient nature of PQD fragmentation. 
Introduction 
  Mass spectrometry-based proteomic analyses rely on the fragmentation 
of peptides in the gas phase to fragment ions. The resulting fragmentation ions 
are then used to determine the sequence of the peptide, and from this, the 
associated protein can be identified. The primary method for peptide 
fragmentation is collision induced dissociation (CID) (Swaney et al., 2008).  The 
LTQ, Orbitrap, q-TOF, and MALDI-TOF/ TOF instruments are all capable of 
performing CID fragmentation of peptides. CID is best utilized for small and 
unmodified peptide cations (Dongre et al., 1996; Good et al., 2007; Huang et al., 
2005). For the ion trap, resonance excitation of the peptide is achieved through 
intermolecular collisions with the peptide and an inert gas.  The collision energy 
transferred to peptides in CID results in the vibrational excitation of the peptide 
and is distributed among the covalent bonds of the peptide chain.  When the 
internal energy transferred to the peptide in CID exceeds the activation barrier for 
bond cleavage, the peptide can fragment. These fragments can be detected by 
the mass spectrometer if they occur within the timescale of the instrument. 
Fragments produced are dependent on the size, sequence, and charge state of 
the peptide as well as the amount of collision energy supplied.  For CID, the 
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fragmentation typically occurs at the amide bonds of the peptide backbone due to 
the low activation barrier that exists at these locations. This generates the 
characteristic b- and y-product ions seen in CID spectra (Swaney et al., 2008).  
The model that is typically used to describe how peptides fragment in CID 
is the “mobile proton theory”  Wysocki et. al., 2000).  The mobile proton theory 
arises from the observation that fragmentation of most protonated peptides 
requires the involvement of a proton at the cleavage site.  If an amino acid side-
chain holds a proton, energy will be required to move the proton from the basic 
side-chain to the peptide backbone to induce dissociation.  Common proteomic 
approaches involve the use of trypsin as the proteolytic enzyme, and therefore, 
peptides produced as such contain at least two basic residues.  The addition of 
energy supplied by the tandem mass spectrometer alters the initial population of 
protonated forms in favor of those with energies higher than that of the most 
stable structure (Wysocki et. al., 2000).  Protonation of backbone sites induces 
charge-directed cleavage of the backbone to generate b- and y-type sequence 
ions in CID.  Since basic residues are more electronically rich, they more tightly 
sequester protons.  This tendency for more basic residues to sequester protons 
increases the charge-directed cleavage at these residues in the peptide 
backbone.  A prominent example of this is observed for peptides containing an 
internal proline residue.  Cleavage of a peptide at the C-terminal side of a proline 
is energetically unfavorable and results in an intense b-type ion housing the 
protonated proline residue (Schlosser and Lehmann, 2000).  This diagnostic trait 
can be useful in de novo sequencing of experimental spectra. 
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Although CID is effective in generating ion series suitable for peptide 
sequencing, some caveats exist that diminish its ability to fragment particular 
peptides. Internal basic residues and proline amino acids can prevent the 
random protonation of the peptide backbone in accordance with the mobile 
proton theory. These residues direct amide bond dissociation to specific sites 
and can inhibit the fragmentation of the peptide resulting in an insufficiently 
diverse set of sequencing ions (Schlosser and Lehmann, 2000; Mikesh et al., 
2006). The common use of trypsin as a protease alleviates some of these 
concerns by generating peptides with a basic residue at the C-terminus. Labile 
PTMs such as phosphorylation and glycosylation also present alternative low-
energy fragmentation pathways. In these cases, the aforementioned neutral loss 
events can occur, generating spectra with insufficient sequencing ion coverage. 
Some PTMs can also inhibit the random protonation of the peptide backbone and 
subsequently inhibit fragmentation via CID (Tsaprailis et al., 1999). 
To overcome some of the limitations of true CID, Thermo Scientific 
introduced a variation of CID termed pulsed-q collision induced dissociation 
(PQD).  PQD occurs under controlled resonance excitation amplitude and main 
RF amplitude.  The first step of PQD places the precursor ion at an elevated Q 
value of 0.6-0.8 and pulses the ion with a high amplitude resonance excitation 
pulse.  This pulse kinetically excites the precursor ion.  The ions are then held at 
the elevated Q value for approximately 100 s to convert the kinetic energy of the 
precursor ion into internal energy through collisions.  This short time frame 
prevents significant bond dissociation.  The final event of PQD pulses the 
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precursor ion‟s Q value to a lower state by a rapid drop of the RF amplitude.  
Following this rapid drop, precursor ions undergo fragmentation to produce 
spectral information.  The process of activating at both high Q values generates 
sequencing fragments while the activation at the low Q values traps low m/z 
fragments.  Therefore PQD retains the lower 1/3 of the spectra typically lost in 
normal CID (Bantscheff et al., 2008). 
An alternative fragmentation method termed electron-capture dissociation 
(ECD) has the ability to overcome some of the limitations posed by CID. In ECD, 
protonated peptides are held in the Penning trap of an FT-ICR and exposed to a 
beam of electrons at thermal or near-thermal energies. The capture of the 
thermal electron by the protonated peptide results in backbone fragmentation 
without intramolecular vibrational energy redistribution (Udeshi et al., 2007). ECD 
fragmentation generally produces c- and z-ions series as opposed to the b- and 
y-ions generated in CID.  ECD is a size and sequence independent process and 
can be used to fragment intact proteins.  However, for ECD to be efficient, the 
sample must be in a dense population of the thermal electrons. This situation is 
technically difficult to achieve on instruments using electrostatic radiofrequency 
fields to isolate ions but is easier in FT-ICRs that use static magnetic fields. In 
addition, ECD spectra suitable for sequencing require the averaging of a large 
number of scans on a time scale of minutes. This necessitates the introduction of 
large amounts of analyte into the instrument and precludes the detection of 
peptides or proteins in a complex sample mixture (Udeshi et al., 2007).  
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The use of a similar fragmentation method called electron transfer 
dissociation (ETD) overcomes the limitations generated by ECD. ETD uses 
ionized radical anions of polyaromatic hydrocarbons to react with multiply 
protonated peptides in the gas phase. These radical anions are added and 
stored in the linear quadrupole ion trap of the mass spectrometer along with the 
peptides ions. The radical anions transfer an electron to the ionized peptides and 
the resulting charge reduced peptide fragments in a mechanism believed to be 
analogous to ECD, generating characteristic c- and z-sequencing ions (Syka et 
al., 2004). The fragmentation patterns generated with ECD and ETD are 
independent of peptide length, amino acid composition, and the presence of 
PTMs (Udeshiet al., 2007). This fragmentation process is highly efficient and 
occurs on a millisecond time scale. Therefore, ETD is sensitive down to 
femtomole amounts of sample and occurs on a time scale corresponding to 
current chromatographic separation techniques (Syka et al., 2004). The main 
benefit of this fragmentation technique is its ability to preserve labile PTMs while 
still allowing sufficient amide bond cleavage to generate spectra from which 
sequencing information can be obtained. However, this method suffers from a 
decrease in fragment ion production as the precursor ion charge decreases 
(Swaney et al., 2007).  
A recent study has utilized a hybrid approach of ETD and CID (ETcaD) to 
target the nondissociative electron transfer product ions of ETD with CID. This 
method resulted in median sequence coverage of 88.9% for ETcaD as opposed 
to 62.5% for ETD and 77.4% for CID alone (Swaney et al., 2007). Other studies 
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have utilized ETD to identify PTMs, namely phosphorylation. One group used 
CID based fragmentation to detect over 1000 phosphopeptides but was only able 
to define 383 sites of phosphorylation, largely due to the neutral loss events on 
the modified peptides (Udeshi et al., 2007). Using an LTQ modified with ETD, 
1252 sites of phosphorylation on 629 proteins of a complex mixture were 
identified (Udeshi et al., 2007). A separate analysis of the overlap between 
phosphopeptides identified with ETD and CID found that only 17.9% of the sites 
identified were shared among the two datasets generated (Swaney et al., 2008). 
This suggests that the best approach to fragmenting and identifying sites of 
PTMs may be a combination of CID and ETD. 
Another variant of CID has been introduced in hybrid Orbitrap mass 
spectrometers taking advantage of the presence of a C-trap in their design. This 
method of fragmentation known as higher energy collision dissociation cell (HCD) 
allows for the retention of the low m/z region on the spectra where reporter ions 
are often encountered (Olsen et. al., 2007).   HCD is performed by injecting 
peptide ions from the ion trap into a collision cell at the far side of the C-trap.  
Fragment ions are transferred back to the C-trap for activation and subsequent 
dissociation and passed to the Orbitrap mass analyzer via a supplementary 
hexapole (Olsen et. al., 2007).  Analysis in the Orbitrap results in high resolution 
and high mass accuracy data.  HCD fragmentation is similar to fragmentation in a 
Q-TOF and overcomes the problems of low mass cutoff seen in ion trap 
fragmentation (Nagaraj et. al., 2010).  However, since fragmentation ions in HCD 
are detected in the Orbitrap as opposed to the ion trap in CID or PQD, the 
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technique is limited by the lower duty cycle of the instrument (Kocker, 2009).  In 
addition, HCD has been correlated with a decrease in sensitivity due to a lack of 
backbone fragments useful for peptide identification (Dayon et. al., 2009).  It is 
important to note that at the time this study was investigated, we were not 
equipped with an instrument capable of performing HCD.  Recent group have 
proven the utility of combining CID with HCD activation modes in an LTQ-
Orbitrap mass spectrometer for the precise identification of peptides without 
compromising peptide identifications with the linear ion trap analyzer.  To 
accomplish this, both HCD and lower energy CID were acquired for each 
selected precursor ion.  CID generated spectra were used for peptide ion 
identification and HCD spectra were used for quantification (Dayon et. al., 2010). 
Summary 
 To investigate the utility of using PQD for protein quantitation with the 
iTRAQ system I used affinity purified protein samples and a LTQ linear ion trap 
mass spectrometer not equipped with a HCD cell.  The ability to identify peptides 
at varied pulsed-Q levels was evaluated and compared to a set of proteins 
identified at varied percent CID levels.  After determining what PQD percentage 
resulted in reliable peptide identifications, iTRAQ labeling was performed on a 
set of peptide standards.  I then evaluated at what percent PQD level iTRAQ 
reporter ions could be detected and compared this to reporter ion detection 
obtained using CID. 
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Materials and Methods 
Protein extracts 
 TAP-Rpg1 strains were grown, purified, trypsin digested, and desalted as 
previously described from 4L of culture (Powell et. al., 2004; Link et. al., 2005).  
Desalted sample was vacuum centrifuged to dryness for use in iTRAQ 
experiments. 50 g of material was loaded onto the reverse phase column for 
MS/MS analysis.  The 6 protein standard mixture utilized for reporter ion 
detection is supplied with the iTRAQ kit.  This mixture consisted of bovine serum 
albumin, -galactosidase, -lactalbumin, -lactoglobulin, lysozyme, and 
apotransferrin.  
iTRAQ labeling 
 iTRAQ labeling reagents used were obtained from the iTRAQ 2-Plex 
methods development kit (Applied Biosystems).  Dry samples were reconstituted 
in 30 L of dissolution buffer (supplied with the kit), vortexed for 30 s at room 
temperature and centrifuged briefly.  iTRAQ reagents were brought to room 
temperature from -20C.  Seventy L of ethanol was added to each iTRAQ 
reagent vial (114 and 117 reporter tags).  Each vial was vortexed for 1 min then 
briefly centrifuged.  The contents of each iTRAQ reagent vial were added to 50% 
of the supplied 6 protein mixture (129 g) standard in a 1:1 ratio.  Each vial was 
vortexed, briefly centrifuged, and incubated at room temperature for 1 h.  
Samples were combined and desalted as previously described to remove iTRAQ 
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reagents and vacuum centrifuged to dryness (Powell et. al., 2004; Link et. al., 
2005).  Dry samples were reconstituted in 40 L 0.1% formic acid.   
Mass spectrometry 
 Experiments were performed on a Thermo LTQ mass spectrometer 
coupled to an Eksigent NanoLC system (Thermo Electron, Inc) (Link et. al., 1999; 
Sanders et. al., 2002; Powell et. al., 2004).  Data acquisition of samples was 
performed as previously described with the exception that either 3 CID or 3 PQD 
scans were performed following the initial full MS scan.  Normalized collision 
energies were varied for both PQD and CID in individual experiments from 20% 
to 45% at 5% step intervals. 
Mass spectrometry data analysis 
 Spectral information in the low mass range for the reporter ions of iTRAQ 
was visualized with the Thermo‟s supplied Xcalibur software.  To process and 
analyze the mass spectrometry data, the program extractms2 was used to 
generate an ASCII peak list and identify +1 or multiply charged precursor ions 
from native *.RAW mass spectrometry data files (Jimmy Eng and John R. Yates 
III, unpublished). Tandem spectra were searched with no protease specificity 
using SEQUEST-PVM  (Sadygov et. al., 2002) against the SGD yeast_orfs 
database containing 6,000 entries with a static modification of +57 on C (addition 
of a carbamidomethyl group). In addition, the isobaric tags used in iTRAQ add 
+145 to the N-terminus and lysine residues.  For multiply charged precursor ions 
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(z  +2), an independent search was performed on both the +2 and +3 mass of 
the parent ion.  Data were processed and organized using the BIGCAT software 
analysis suite (McAfee et al., 2006). A weighted scoring matrix was used to 
select the most likely charge state of multiply charged precursor ions (Link et al., 
1999; McAfee et al., 2006). From the database search, tryptic peptide sequences 
with SEQUEST cross-correlation scores (Cn)  1.5 for +1 ions,  2 for +2 ions, 
and  2 for +3 ions were considered significant and used to create a list of 
identified proteins. 
Results 
Experiment Workflow 
 To establish the utility of using PQD to identify and quantify proteins in 
complex mixtures, I first had to determine if sufficient fragmentation information 
could be interpreted from MS/MS spectra generated using PQD.  To this end, I 
performed PQD based fragmentation experiments using affinity purified eIF3 
samples.  The results of the experiments with varied PQD were compared to 
results of fragmentation and identifications obtained using CID.  I was able to 
establish a defined percent PQD level to reliably generated MS/MS spectra that 
would lead to peptide identifications.  With these parameters established, I 
extended this approach to evaluate its utility for quantitating proteins using the 
iTRAQ system coupled to PQD in the mass spectrometer.  For the latter set of 
experiments, a six protein standard mixture was labeled with the iTRAQ reagents 
at defined ratios and analyzed with both PQD and CID.  The results of this set of 
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experiments yielded operating parameters for the mass spectrometer for 
detection of iTRAQ reporter ions operating in PQD mode. 
PQD vs. CID for peptide identification 
The default instrument parameter for normalized collision dissociation 
energy in the linear trap is 35%.  In an attempt to find a comparable PQD 
normalized collision dissociation energy, this value was varied within the LTQ 
instrument settings.  First, a sample of TAP purified and digested eIF3 protein 
complex was analyzed by 35% normalized collision dissociation energy in CID.  
The resulting Sequest search returned 150 protein identifications within the 
previously described data filtering parameters.  Results for the PQD normalized 
collision dissociation energy varied from 20-45% are shown in Table 4-1.  A 
comparison of 35% normalized collision energy for a peptide generated in both 
CID and PQD appear similar in their fragmentation patterns although the PQD 
spectrum contains more noise (Figure 4-1). 
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%PQD 
Proteins 
Identified 
Peptides 
Identified 
20 13 41 
25 100 348 
30 87 300 
35 108 313 
40 94 232 
45 57 125 
 
Table 4-1.  Proteins identified for varied PQD normalized collision dissociation 
energies. 
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Figure 4-1.  CID vs. PQD spectra for a Nip1 peptide.  Both spectra were generated 
using 35% normalized collision energy.  The top spectra was generated using CID, while 
the bottom was generated using PQD.  Both spectra were matched by Sequest to the 
Nip1 peptide FDASANLSYQPIDQWK. 
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PQD iTRAQ reporter ion detection 
 The six protein standard supplied with the iTRAQ kit was used to evaluate 
the ability of PQD to reliably detect iTRAQ reporter ions in the low m/z range 
(114-117).  The previous set of experiments established that a normalized 
collision energy of between 25-35% provided the most protein identifications per 
complex protein mixture.  Next we tested PQD‟s ability to detect the 114 and 117 
m/z reporter ions of iTRAQ in normalized collision energies of between 15-35%.  
At a normalized collision energy of 15%, we were unable to match any spectra to 
peptides in the 6 protein standard iTRAQ mix.  Manual inspection of the spectra 
reveals that very little sequencing ion information is obtained at the low 
percentage normalized collision energies (Figure 4-3 A).  This same case holds 
true for a 20% normalized collision energy, although a few spectra did match to 
peptides in the mixture (Figure 4-3 B).  Upon increasing the normalized collision 
energy to 25%, we observed a marked increase in spectra matching peptides in 
the mixture.  This trend peaked at 30% normalized collision energy and trailed off 
at 35% (Table 4-2).  Investigating the reporter ion m/z range reveals that at 30% 
normalized collision energy, 100% of the spectra that corresponded to peptide 
hits in Sequest also contained peaks at either of 114 m/z or 117 m/z or both.  
However, when comparing relative reporter ion intensities for normalized collision 
energies ranging from 25-35% for a single peptide, we observe inconsistent 
patterns (Figure 4-2). 
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Table 4-2.  Various percent collision energies in PQD and the effect this has on 
peptide identification and reporter ion detection.  The PQD collision energies were 
varied between 15 to 35%.  At 30%, the most peptides were identified as well as peaking 
in the percent of the spectra that contained reporter ions. 
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Figure 4-2.  The reporter ion series for the standard peptide YNGVFQECCQAEDK.  
The normalized percent collision energy was varied for each spectrum from 25-35%.  
The expected ratio of peak intensities is expected to be 1:1.  However, the ratios deviate 
from the expected in an unpredictable manner. 
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Figure 4-3.  Spectra of standard mix generated using PQD at 15% (A) and 20% (B).  
The resulting spectra contain very little sequencing ion information at the low PQD 
energies. 
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Discussion 
 We determined that a PQD normalized percent collision energy of 
between 25-35% will yield the best fragmentation data for use in identifying 
proteins in a complex biological mixture (Table 4-1).  However, PQD fails to 
provide as many peptide identifications when spectra are searched as does 
typical CID.  This may be due to the time delay imparted by the pulse in PQD 
whereby the precursor ion can lose kinetic energy via routes other than collision 
energy as the Q is pulsed.  This loss of energy would lead to reduced amide 
bond fragmentation and fewer ions in the spectra for sequencing information.  
This may be of concern for investigators who are looking to maximize proteome 
coverage in an iTRAQ experiment.  The presence of fewer peptides matching to 
spectra also leads to a loss of reporter ion data and thereby quantification 
information.   
A study by Bantscheff and coworkers found that PQD suffered from poor 
peptide fragmentation efficiency (Bantscheff et. al., 2008).  PQD spectra that 
were observed were dominated by the unfragmented precursor ion indicating 
poor fragmentation efficiency and a resulting limited iTRAQ reporter ion intensity 
(Bantscheff et. al., 2008).  This group spent considerable time and effort in 
optimizing the parameters to obtain the most efficient fragmentation possible.  
They found that careful optimization of activation Q, delay time, ion isolation 
width, number of microscans, and the number of trapped ions, fragment ion 
intensities can be generated that enable the accurate quantification at the 100 
amol level (Bantscheff et. al., 2008).  Bantscheff and coworkers also possessed 
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a mass spectrometer capable of HCD, unlike the one available for this study.  
Interestingly, they found that PQD outperformed HCD in terms of the lower limit 
of quantification with a 10X greater sensitivity.  However, HCD spectra generated 
more reliable sequencing information (Bantscheff et. al., 2008). 
 With the normalized percent collision energy for PQD established at 
approximately 30%, we next wanted to determine at which percentages would 
give us the most reliable detection of the reporter ions.  By varying the 
normalized collision energy percentages between 15 and 35%, we found that 
30% normalized collision energy afforded the most reporter ion information for 
the number of spectra generated.  Under these conditions, 100% of the spectra 
generated by the normalized collision energy values contained a reporter ion at 
114 and/or 117 m/z.  Although a normalized collision energy of 30% resulted in 
fewer overall peptide identifications and a good starting value for investigating 
the applicability of this technique to using iTRAQ to quantitate complex protein 
mixtures.  However, the inconsistent relative reporter ion intensities do raise 
some concern as to the widespread applicability of this technique (Figure 4-2).   
 Griffen and coworkers found that an optimized collision energy between 5-
30% results in the greatest number of reporter ions using the iTRAQ system 
(Griffin, 2007).  Interestingly, they also determined that this value is instrument- 
dependent and may change with routine maintenance of an individual instrument 
(Griffin, 2007).  An approach they explored to improve the detection of iTRAQ 
reporter ions was to increase microscan acquisition and repeat spectral counts to 
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improve the quantification data.  However, this results in an increased duty cycle 
time for the instrument at the cost of identifying fewer peptides.  Overall, this 
group found that in order to effectively use PQD and iTRAQ, they had to develop 
software to calculate abundance ratios of reporter ions by summing intensities 
across spectra matching to each protein (Griffin, 2007). 
We attempted to extend the iTRAQ approach to analyzing complex protein 
mixtures using the iTRAQ system.  Affinity purified eIF3 was labeled with the 114 
and 117 reporter groups and mixed in a 1:2 ratio.  However, among peptides 
from the same protein, we detected widely varying ratios of reporter ions.  Some 
groups have found mild success using PQD and iTRAQ, namely Zhang and 
colleagues who used this approach to profile serum proteins (Zhang et. al., 
2008).  They were able to use SDS-PAGE to reduce overly abundant proteins in 
the mixture and quantify the relative abundance of 64 proteins from a total of 84 
identifications (Zhang et. al., 2008).  Making useful sense of the iTRAQ data 
necessitates new bioinformatics tools for calculating relative abundances by 
averaging reporter ion intensities across multiple peptides for a single protein to 
get confident data.  Griffen and coworkers found similar results and developed 
specialized software to calculate relative abundances based on this observation.  
Since this was beyond the scope of what we wanted to accomplish in the lab, we 
abandoned this study here.  Several groups have published on the utility of using 
PQD with iTRAQ labeling with limited success (Kocher et. al., 2009; Yang and 
Wu, 2009; Bantscheff et. al., 2008).  Overall, this approach has not found 
widespread applicability in the field of proteomics. 
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CHAPTER V 
 
SUMMARY AND CONCLUSIONS 
 
The main focus of this dissertation was a comprehensive investigation into 
the interactions and phosphorylations of the eukaryotic translation initiation factor 
eIF3.  The central hypothesis of my thesis is that there are unexpected and 
unidentified eIF3 protein-protein interactions and protein phosphorylations that 
regulate its function and activity in the essential process of translation initiation.  
The summary and conclusions section is divided into three parts.  The first part 
deals with characterizing the proteins that interact with the eIF3 complex and 
identifying novel interacting partners.  The second part deals with identifying 
phosphoproteins within the eIF3 complex and localizing these observed events to 
specific amino acid residues within the core components of eIF3.  Each of the 
first two parts will address the biological significance of the findings as well as 
suggest further routes of investigation that may provide additional information as 
to eIF3‟s essential role in protein translation. The third and final section will 
address the utility of using pulsed Q-dissociation for the reliable detection of 
iTRAQ labeled peptides for quantitative proteomics. 
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Part 1:  The eIF3 Interactome 
eIF3 is crucial for the assembly and function of the 48S preinitiation 
complex.  Previous studies have shown that eIF3 is composed of five core 
proteins in S. cerevisiae (Hinnebusch et. al., 2004).  Additional interactions with 
noncore components of eIF3 have been identified with Hcr1, eIF1, and eIF5 
(Valasek et. al., 2001; Hinnebusch et. al., 2004; Asano et. al., 2001).  The broad 
range of functions postulated for the eIF3 complex leads to the hypothesis that 
there are yet to be identified proteins interacting with the eIF3 complex.  To test 
this hypothesis, I performed affinity purifications of the components of eIF3 and 
determined the optimal strategy for obtaining the largest yield of the eIF3 
complex.  I coupled the optimized purification strategy to high sensitivity mass 
spectrometry based proteomics to obtain an extensive list of proteins interacting 
with eIF3. 
I determined, in agreement with the previous work on eIF3, that its core 
complex is composed of Rpg1, Nip1, Prt1, Tif34 and Tif35.   I was also able to 
detect interactions of eIF3 with Hcr1, eIF1, and eIF5, consistent with previous 
studies.  Utilizing normalized spectral counting to estimate the relative 
abundance of known interacting proteins, we were able to identify novel 
intermolecular interactions of eIF3 with Fun12 and Pab1.  Reciprocal affinity 
purifications of Fun12 and Pab1 revealed that they also copurified with the core 
members of eIF3.  Fun12 has been shown to facilitate the joining of the 40S and 
60S ribosomal subunits in the terminal step of translation initiation (Pestova et. 
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al., 2000).  In addition, fun12 null strains have a slow growth phenotype and 
altered polysome profiles suggesting a defect in translation initiation (Choi et. al., 
1998).  eIF3 has been shown to interact with the 40S subunit in the assembly of 
the 48S pre-initiation complex (Hinnebusch et. al., 2004; Asano et. al., 2001).  
This led to the postulation that the interaction of eIF3 with Fun12 links the 
formation of the pre-initiation complex with the binding of the 60S ribosome and 
the termination of translation initiation.   
The finding that Pab1 associates with eIF3 is consistent with the current 
model of its function in translation.  Pab1 has been shown to facilitate the joining 
of the 5‟ and 3‟ ends of mRNA by binding the initiation scaffold protein eIF4G 
(Tarun and Sachs, 1996;Cosson et. al., 2002).  eIF4G along with eIF4A and 
eIF4E form the eIF4F complex (Hernandez and Vazquez-Pianzola, 2005).  eIF4F 
facilitates the interaction of the 43S pre-initiation complex with the 5‟ cap 
structure of the mRNA producing the 48S pre-initiation complex.  Efficient 
formation of the 48S pre-initiation complex is also dependent on eIF3 
(Hinnebusch et. al., 2004).  Similar to Fun12, pab1 deleted strains have 
decreased levels of translation initiation (Sachs and Davis, 1990).  Our finding 
that PABP interacts with the eIF3 complex complements the previous findings 
and suggests a role in this interaction in the efficient formation of the 48S pre-
initiation complex. 
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Model and Future Directions 
These two findings, namely the interaction of eIF3 with both Fun12 and 
Pab1, allow us to expand upon the model of what is currently believed to happen 
in translation initiation.  Upstream of the cooperation of eIF3 with Fun12 is where 
the significance of the interaction between eIF3 and Pab1 may occur.  Pab1 
functions to circularize mRNA to facilitate formation of the 48S complex, a 
process for which eIF3 is also necessary.  A direct interaction between eIF3 and 
Pab1 could help to stabilize the circularization of mRNA and the subsequent 
formation of the 48S complex.  Since eIF3 functions to recruit the 40S subunit to 
form the 48S preinitiation complex and Fun12 functions in the formation of the 
80S ribosome, it seems the two operate synergistically and directly to begin 
translation elongation following the efforts of Pab1 to form the 48S pre-initiation 
complex.  
Further investigations are warranted to probe the true nature of the 
interactions of eIF3 with Fun12 and Pab1.  Dr. Alan Hinnebusch‟s laboratory has 
performed work to map domains in eIF3 that interact with other proteins and 
initiation factors.  It is possible that some of the uncharacterized domains of 
components of eIF3 interact with either or both Fun12 and Pab1.  Analyzing 
mutants lacking these domains or mutants lacking sections of Fun12 or Pab1 
using mass spectrometry based approaches may result in an abolition of the 
interactions observed between eIF3 and these two proteins.  Additionally, these 
domain mutants may harbor defects in translation initiation that would manifest in 
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growth defects, translation defects, drug sensitivities, or altered polysome 
profiles.  It would be interesting to generate and test such mutants in an attempt 
to discern the true consequence of the observed interactions.  
Part 2:  The Phosphorylation State of eIF3 
Protein phosphorylation is a dynamic posttranslational modification that is 
widespread within the eukaryotic proteome.  This modification‟s affects range 
from stochastic to specifically defined and targeted.  While investigating the 
interactome of the eIF3 complex, it was found that the Casein Kinase 2 (CK2) 
complex copurifies with eIF3.  Reciprocal isolations of components of the CK2 
complex also isolated components of eIF3.  The observation that a protein kinase 
copurifies with eIF3 led me to postulate that one or several components of the 
eIF3 complex are phosphorylated in vivo. 
To test this hypothesis, cell cultures containing TAP-Rpg1 were labeled 
with ATP containing 32P.  The resulting mixture was affinity purified, separated 
via SDS-PAGE, transferred to nitrocellulose, and exposed to film.  This 
experiment revealed a prominent band in the molecular weight region 
corresponding to the Nip1 protein of the eIF3 complex.  This result indicated that 
Nip1 is phosphorylated in vivo.  This evidence, along with the previous results 
showing that CK2 copurifies with eIF3, raised the question as to whether CK2 
specifically targets eIF3 for the phosphorylation of Nip1.  An in vitro kinase assay 
was performed with a broad range of kinases found in yeast.  This experiment 
revealed that CK2 had the ability to phosphorylate Nip1 in vitro.  Interestingly, a 
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less prominent signal was observed for Prt1 indicating that CK2 also has the 
ability to phosphorylate this component of eIF3.  One reason for observing the 
signal in vitro and not in vivo for Prt1 could be that the signal in the latter 
approach may be too weak to be detectable by autoradiography.  Conversely, 
this observation could simply be an artifact of using an in vitro approach whereby 
one loses a cellular regulatory event that inhibits the phosphorylation of Prt1 in 
vivo. 
The next step in determining the cellular consequences of the observed 
phosphorylations was to localize the modification to specific amino acid side-
chains.  The traditional biochemical approach to elucidating which S, T, or Y 
residues are phosphorylated is Edman degradation followed by thin layer 
chromatography.  This approach is laborious, requires large amounts of material, 
and utilizes additional radioactivity.  I chose a high throughput approach that 
takes advantage of the sensitivity of mass spectrometry.  The strategy with this 
approach is to affinity purify eIF3 and then use proteomics to determine which 
sites on the proteins comprising eIF3 are phosphorylated.  This set of 
experiments identified two sites on Prt1, S61 and T746, that are phosphorylated 
in vivo.  However, no phosphoresidues were identified on sites in Nip1 with this 
approach.  As previously discussed, this can be attributed to ion suppression by 
an unmodified form of Nip1 masking the signal from the phosphorylated form or 
-elimination of phosphoric acid from phosphorylated Nip1 resulting in a loss of 
signal in the mass spectrometer. 
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A variety of techniques exist that allow for the specific enrichment of 
phosphopeptides that increase the likelihood of identifying them downstream 
using proteomic approaches.  Of the available techniques, I chose to perform 
immobilized metal affinity chromatography (IMAC) to selectively enrich for 
phosphopeptides from affinity purified samples of the eIF3 complex.  This 
approach allowed for the identification of a triply phosphorylated peptide 
containing S98, S99, and S103, from Nip1.  Doubly phosphorylated forms of the 
same peptide were also detected with S99 being constitutively modified and the 
second phosphorylation event involving either S98 or S103.  The previously 
identified singly phosphorylated peptides from Prt1 were not identified with the 
IMAC approach.  This is a common limitation of IMAC in that it preferentially 
binds multiply phosphorylated peptides leading to the loss of singly 
phosphorylated species (Ficarro et al., 2002).  The localization of the 
phosphorylation to this region of Nip1 is an interesting observation since this 
section of Nip1 is proposed to mediate its interaction with Prt1.  It could be 
speculated that losing the phosphorylation events will greatly decrease the 
polarity in this particular region of Nip1.  A loss of strong polar interactions 
between Prt1 and Nip1 could reduce the stability of the eIF3 complex.  The net 
result would be a smaller pool of eIF3 available to perform its native biological 
functions.  This could in turn cause a biological defect in cells that lack the ability 
to form the stabilizing interaction between Nip1 and Prt1. 
I chose to focus on the observed sites in Nip1 for further investigation 
since they may play a role in the stability of the eIF3 complex.  To determine if 
132 
 
there were any other sites of phosphorylation on Nip1, I performed an in vitro 
inhibitory kinase assay to see if the signal observed for Nip1 would be abolished.  
The inhibitor was a commercially synthesized peptide identical in sequence to 
the peptide identified via mass spectrometry.  Upon introduction of the peptide 
inhibitor to the assay, the signal in the corresponding Nip1 region is markedly 
decreased but not completely abolished.  This result could indicate that there are 
more sites of phosphorylation on the Nip1 protein that were not identified by 
either proteomic approach attempted.  The next step was to investigate the in 
vivo consequences of losing the three phosphorylation sites identified on Nip1.  
To accomplish this, a mutant form of Nip1 (nip1S98,99,101A) was generated.  
Repeating the autoradiography experiments utilizing the nip1S98,99,101A strain 
revealed an approximately 41% reduction in the observed signal in the Nip1 
region.  This result is further evidence that there still exist unidentified sites of 
phosphorylation on Nip1 that require additional work to identify. 
The Biological Significance of nip1S98,99,101A 
Since the region of Nip1 that I identified as phosphorylated is speculated 
to be involved in stabilizing the formation of the eIF3 complex, I hypothesized 
that the mutant nip1S98,99,101A strain would have a measurable biological 
defect.  Defects in factors involved in translation initiation often manifest in 
reduced overall rates of protein synthesis.  However, 35S-methionine 
incorporation experiments showed no measurable difference between the rate of 
translation between wild-type and nip1S98,99,101A.  Strains harboring defects in 
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the translation machinery often show increased sensitivity to drugs such as 
rapamycin, paromycin or cyclohexamide.  Again there were no detectable 
differences in the growth of cells exposed to these drugs and other stresses such 
as osmotic and temperature shock when comparing the wild-type and 
nip1S98,99,101A strains. 
An interesting observation was made throughout the experiments that 
required liquid culturing of the mutant strain.  Overnight cultures of 
nip1S98,99,101A consistently resulted in a smaller cell pellet following 
centrifugation when compared to the wild-type cells.  This observation led to the 
speculation that perhaps the nip1S98,99,101A strain has a detectable defect in 
its growth rate.  Cell counting based experiments were performed to investigate 
this observation.  These investigations revealed that the wild-type strain doubled 
every 111 ± 12 min, within the normal range for S. cerevisiae.  However, the 
nip1S98,99,101A mutant strain doubled every 148 min ± 10 min, a 33% increase 
(p-value = 0.00687).  Complementing the mutant strain with a wild-type Nip1 
plasmid results in a restoration of the doubling time to normal levels (112 min ±8 
min). 
Model and Future Directions 
The largest component of eIF3, Rpg1, has been suggested to be essential 
for G1-S phase transition and to be involved in the growth control of yeast cells 
(Kovarik et. al., 1998).  A separate study conducted in human cells found that 
reducing eIF3a (Rpg1) expression also reduced cell proliferation by elongating 
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the cell cycle without changing the cell cycle distribution (Dong, 2009).  These 
studies highlight a link between the growth rate of cells and the concerted action 
of the proteins composing eIF3.  The model that I propose follows these same 
lines in that the phosphorylation of Nip1 introduces a key structural element that 
is essential for the efficient formation of the eIF3 complex.  Perhaps the 
increased polarity provided by the phosphorylations stabilizes interactions with 
the Prt1 protein as this region of Nip1 is suspected to be involved in Nip1-Prt1 
contacts.  The resulting depletion of the stable eIF3 complex decreases the 
growth rate of the cells as observed by Kovarik and coworkers for Rpg1 depletion 
(Kovarik et. al., 1998). 
Additional work is necessary from what was observed during the above 
experiments.  Prt1 was found to contain two sites of phosphorylation at S61 and 
T746.  Generating mutants lacking either one or both of these sites and 
performing experiments analogous to those performed on the Nip1 mutant could 
generate interesting results that would lead to further insights into the role of 
eIF3.  These strains could possibly have more pronounced defects in their 
biology than what was observed for the nip1S98,99,101A mutant.  The 
autoradiography experiments done with nip1S98,99,101A revealed a modest 
reduction in the amount of 32P incorporated onto Nip1.  Experiments using an 
alternative enrichment strategy such as immunoaffinity purification or TiO2 
enrichment followed by mass spectrometry could reveal additional 
phosphopeptides from Nip1.  The generation of phosphomimetic strains that are 
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incapable of being dephosphorylated could also reveal further insight into the 
significance of the identified modifications. 
Part 3:  Pulsed-Q Dissociation and iTRAQ 
Quantitative mass spectrometry-based proteomic techniques are providing 
researchers with powerful tools to investigate cellular biology.  Quantifying 
differences in the proteome under differential states can yield valuable 
information about disease and aberrant cellular processes.  The utility of these 
approaches owes to the observation that measurable differences in the levels of 
proteins can be indicative of particular states within cells or tissues.  The advent 
of iTRAQ reagents to quantify either the relative or absolute amounts of proteins 
in biological samples has become a widespread technique in proteomics.  This 
provides a robust method simultaneously identifying proteins in complex mixture 
while yielding quantification data.  However, ion trap mass spectrometers are 
typically not useful for iTRAQ analysis because the reporter ions generated from 
the fragmentation of the iTRAQ tags are lost along with the lower 1/3 of the 
MS/MS data.   
To circumvent this caveat of ion trap collision induced dissociation (CID), 
Thermo Electron, Inc. introduced pulsed-Q dissociation (PQD).  The process of 
PQD involves activating the ions within the mass spectrometer‟s ion trap at both 
high Q values to generate sequencing fragment ions and activation at the low Q 
values to trap low m/z fragments.  To this end, I hypothesized that an ion trap 
mass spectrometer capable of PQD could successfully fragment peptide ions for 
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sequencing while still providing low m/z iTRAQ reporter ions for quantitative 
studies.  The ultimate goal was to use the knowledge gained in this study and 
extent it to the study of the eIF3 complex.  Namely, this technique could prove 
advantageous in determining the relative ratios of eIF3‟s core components with 
its interacting partners. 
The first goal of the study to evaluate the utility of PQD with iTRAQ was to 
determine if sufficient fragmentation of the precursor peptide could be 
accomplished to yield detectable ions for sequencing.  The percent Q was varied 
and compared with complex mixtures of proteins analyzed with CID.  I 
determined that a PQD normalized percent collision energy of between 25-35% 
will yield the best fragmentation data for use in identifying proteins in a complex 
biological mixture.  However, PQD fails to provide as many peptide identifications 
when spectra are searched as does typical CID.  I speculate that this observation 
may be due to the time delay imparted by the pulse in PQD whereby the 
precursor ion can lose kinetic energy via routes other that collision energy as the 
Q is pulsed.  The resulting spectrum would contain fewer fragmentation ions for 
sequencing as a result of the delay in PQD.  The loss of kinetic energy during 
this delay could also lead to a reduction in signal observed for the iTRAQ 
reporter ion series.  These finding was also observed by other investigators 
where PQD spectra were dominated by the unfragmented precursor ion 
indicating poor fragmentation efficiency and a resulting limited iTRAQ reporter 
ion intensity (Bantscheff et. al., 2008).  However, at the time I attempted these 
experiments, this information was yet to be published. 
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Although fragmentation spectra resulted in a reduced amount of 
sequencing information as compared to CID, protein identifications still resulted 
from the PQD spectra.  I believed that if reliable reporter ions could still be 
detected with PQD induced fragmentation, that PQD could still find utility in 
quantifying peptides with the iTRAQ approach.   I found that between 25 and 
35% PQD collision energy resulted in the optimum number of peptide 
identifications.  I next wanted to investigate at which percent PQD I could reliably 
detect iTRAQ reporter ions.  The six protein standard supplied with the iTRAQ kit 
was used to evaluate the ability of PQD to reliably detect iTRAQ reporter ions in 
the low m/z range (114-117).  Little to no reporter ion signal was detected below 
25% PQD.  Reporter ion detection maxed out at 30% PQD and decreased with 
increasing percent PQD thereafter.   
It is not sufficient to only be able to fragment and detect the reporter ions.  
Reliable quantitative data must be able to be obtained from the intensities of the 
signal observed for the reporter ions.  However, when the intensities of reporter 
ions were compared, the expected 1:1 ratio was not observed.  The patterns for 
reporter ions from the same peptide were inconsistent when compared to other 
peptides generated from the same sample.  Similar results have since been 
reported by other investigators and raise concerns as to the wide spread use of 
this technique in quantitative proteomics (Griffen, 2007).  These experiments 
were repeated with a complex, affinity purified sample of yeast eIF3, mixed in a 
2:1 ratio, resulted in similarly inconsistent results.  I reasoned that perhaps if the 
ratios of reporter ions could be averaged across proteins, more consistent 
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quantitative data may be obtained.  However, this was beyond the scope of the 
study, and it was decided to abandon the approach of using PQD together with 
iTRAQ.   
A limited number of researchers have published on the utility of using 
PQD with iTRAQ labeling with limited success (Kocher et. al., 2009; Yang and 
Wu, 2009; Bantscheff et. al., 2008).  Some of these groups found best results 
were obtained when overly abundant proteins were removed from the complex 
mixtures (Zhang et. al., 2008).  More recently, PQD has been replaced by 
utilizing higher energy c-trap dissociation (HCD).  HCD in hybrid Orbitrap mass 
spectrometers takes advantage of the presence of a C-trap in their design.  HCD 
allows for the retention of the low m/z region on the spectra where reporter ions 
are often encountered (Olsen et. al., 2007).  Recent groups have proven the 
utility of combining CID with HCD activation modes in an Orbitrap for the precise 
identification of peptides as well as quantification (Dayon et. al., 2010). 
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